<SEC-DOCUMENT>0001193125-25-082809.txt : 20250416
<SEC-HEADER>0001193125-25-082809.hdr.sgml : 20250416
<ACCEPTANCE-DATETIME>20250416161539
ACCESSION NUMBER:		0001193125-25-082809
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250415
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250416
DATE AS OF CHANGE:		20250416

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACADIA PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001070494
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				061376651
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50768
		FILM NUMBER:		25843024

	BUSINESS ADDRESS:	
		STREET 1:		12830 EL CAMINO REAL
		STREET 2:		SUITE 400
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		858-558-2871

	MAIL ADDRESS:	
		STREET 1:		12830 EL CAMINO REAL
		STREET 2:		SUITE 400
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d905282d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:acad="http://www.acadia-pharm.com/20250415" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2025-04-15_to_2025-04-15">ACADIA PHARMACEUTICALS INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-511">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-04-15_to_2025-04-15">0001070494</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2025-04-15_to_2025-04-15" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2025-04-15_to_2025-04-15">--12-31</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="acad-20250415.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-04-15_to_2025-04-15"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001070494</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-04-15</xbrli:startDate> <xbrli:endDate>2025-04-15</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-523">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-04-15_to_2025-04-15" format="ixt:datemonthdayyearen" id="ixv-524">April&#160;15, 2025</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Acadia Pharmaceuticals Inc.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-04-15_to_2025-04-15" format="ixt-sec:stateprovnameen" id="ixv-525">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-526">000-50768</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-527">06-1376651</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(State or Other Jurisdiction<br/>of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-528">12830 El Camino Real</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-529">Suite 400</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-530">San Diego</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-04-15_to_2025-04-15" format="ixt-sec:stateprovnameen" id="ixv-531">California</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-532">92130</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area <span style="white-space:nowrap">Code:&#160;<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-533">(858)</ix:nonNumeric>&#160;<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-534">558-2871</ix:nonNumeric></span></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-04-15_to_2025-04-15" format="ixt-sec:boolballotbox" id="ixv-535">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-04-15_to_2025-04-15" format="ixt-sec:boolballotbox" id="ixv-536">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-04-15_to_2025-04-15" format="ixt-sec:boolballotbox" id="ixv-537">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-04-15_to_2025-04-15" format="ixt-sec:boolballotbox" id="ixv-538">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-539">Common Stock, par value $0.0001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-540">ACAD</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-04-15_to_2025-04-15" format="ixt-sec:exchnameen" id="ixv-541">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#160;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-04-15_to_2025-04-15" format="ixt-sec:boolballotbox" id="ixv-542">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;5.03</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;15, 2025, the board of directors (the &#8220;Board&#8221;) of Acadia Pharmaceuticals Inc. (the &#8220;Company&#8221;) adopted amended and restated bylaws of the Company (as amended and restated, the &#8220;A&amp;R Bylaws&#8221;) effective as of such adoption date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of the material changes made to the Company&#8217;s amended and restated bylaws in effect prior to the adoption of the A&amp;R Bylaws (such bylaws, the &#8220;Bylaws&#8221;) by the A&amp;R Bylaws and is qualified in its entirety by reference to the full text of the A&amp;R Bylaws, a copy of which is attached to this Current Report on Form <span style="white-space:nowrap">8-K</span> as Exhibit 3.1 and incorporated herein by reference. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Bylaw&#160;&#167;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Bylaw Change</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">5(a)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revise who has authority to postpone, reschedule or cancel a meeting of stockholders.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Require that stockholders who wish to nominate directors for election to the Board must be stockholders of record at the time of the annual meeting in addition to at the time they give notice of their proposed nomination.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="white-space:nowrap">5(b)(i)-(ii)</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Require certain background information regarding proponents of nominees to the Board and about the nominees themselves.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Limited the maximum number of nominees to the Board that a stockholder may submit to be equal to the number of directors to be elected at the applicable meeting.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Prohibit the nomination of substitute or alternate nominees to the Board without timely notice in accordance with the A&amp;R Bylaws.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">5(b)(iii)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Increase the period of time that an annual meeting date can be moved with respect to the anniversary of the previous year&#8217;s meeting date before an alternative window is applied for purpose of determining timely notice of stockholder proposals. As amended, the alternative window applies if the annual meeting date is advanced by more than 30 days prior to or delayed by more than 70 days (previously 30 days) after the anniversary of the preceding year&#8217;s annual meeting.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">5(b)(iv)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Require additional information regarding proponents of stockholder proposals and director nominees and require such proponents to make certain representations and certifications related to the proposals or nominees, the proponents intended proxy solicitations, the cost of solicitation and the proponent&#8217;s compliance with applicable laws.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">5(c)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Provide explicit procedures for the obligation of a proponent of stockholder proposals and director nominees to update the representations and certifications described in Section&#160;5(b)(iv) above.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">5(e)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Require each proposed nominee to the Board to complete a written questionnaire and make certain representations and certifications about their candidacy, voting commitments, compensation for service and compliance with the Company&#8217;s corporate governance and other policies.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">5(f)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Provide explicit procedures regarding the validity or invalidity of proposals to nominate persons to the Board and the effects of failure by a proponent to follow such procedures.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Require the stockholder (or its qualified representative) proposing a nominee to the Board or any other stockholder business to be present at the meeting of stockholders in order to nominate or present the business.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Incorporate the universal proxy rules in Rule <span style="white-space:nowrap">14a-19</span> under the Securities Exchange Act of 1934, as amended.</td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:92%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Bylaw&#160;&#167;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Bylaw Change</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">6(a)-(b)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Add clarity regarding who can postpone, reschedule or cancel special meetings of stockholders, and clarify how the Board can call a special meeting of stockholders, including its determination of the time and place of a special meeting.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">6(c)-(e)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Conform the advance notice procedures for stockholder proposals at a special meeting to the advance notice procedures for stockholder proposals at an annual meeting (as discussed set forth in Section&#160;5 above).</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">7</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Revise the provisions governing notice of meetings to conform to the current provisions in Section&#160;222 of the General Corporation Law of the State of Delaware (&#8220;DGCL&#8221;).</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">8</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Change the threshold for a quorum for stockholder meetings from:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;the holders of a majority of the outstanding shares entitled to vote; to</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;the holders of a majority of voting power of the outstanding shares entitled to vote.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Change the default threshold for approval of proposals at stockholder meetings from:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;a majority of shares present in person, by remote communication or represented by proxy at the meeting and entitled to vote generally on the subject matter; to</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;a majority of votes cast on such matter, voting affirmatively or negatively (excluding abstentions and broker <span style="white-space:nowrap">non-votes).</span></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">9</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Change the threshold required to adjourn a stockholder meeting from:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;approval by the chairman of the meeting or by a vote of a majority of shares present in person, by remote communication or represented by proxy duly authorized at the meeting; to</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;approval by the chairperson of the meeting or by the stockholders by affirmative vote of a majority of votes cast, voting affirmatively or negatively (excluding abstentions and broker <span style="white-space:nowrap">non-votes).</span></p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Obviate the need for the Company to provide a new notice for an adjourned meeting if the new time and place or means of remote communication are announced at the meeting at which adjournment takes place or is displayed on the website used for purposes of remote stockholder participation at the adjourned meeting.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">10</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Require the stockholder soliciting proxies use a proxy card color other than the &#8220;white proxy&#8221; that is reserved for the Company.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">12</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Modify the required preparation procedures, content and availability of the list of stockholders entitled to vote at a meeting in connection with the current provisions of the DGCL.</td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:92%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Bylaw&#160;&#167;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Bylaw Change</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">18</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cause the procedures governing vacancies on the Board to defer to the Company&#8217;s certificate of incorporation.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">23</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Change the effective date of consents of the Board or committees from:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;the date such consents are filed with the minutes of proceedings of the Board or committee; to</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;the date such consents are completed.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">25(d)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Change the number of directors required for quorum of a committee of the Board from:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;a majority of the authorized number of members of any such committee; to</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;a majority of the members of the committee then serving or, in the case of a committee with two members, one member shall constitute quorum of such committee.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">37(a)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Add procedures for the Board to fix the record date for determining the stockholders entitled to notice of any meeting of stockholders and, separately, the record date for determining the stockholders entitled to vote at such meeting.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">44(a)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Expand the Company&#8217;s mandatory obligation to indemnify its directors and officers to the maximum extent allowed by applicable law.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Limit the Company&#8217;s obligation to indemnity or advance expenses to its directors and officers for certain claims brought against the Company.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">44(c)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Subject to the limitations in Section&#160;44(a), expand the Company&#8217;s mandatory obligation to advance expenses to directors and officers of the Company to the maximum extent allowed by applicable law.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">48</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clarify and expand the types of claims that must be brough in the Court of Chancery of the State of Delaware and any appellate court therefrom as the sole and exclusive forum.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Cause U.S. federal district courts to be the exclusive forum for the resolution of claims arising from the Securities Act of 1933, as amended.</p></td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Exhibit <br/>Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d905282dex31.htm">Amended and Restated Bylaws of Acadia Pharmaceuticals Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">Acadia Pharmaceuticals Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: April&#160;16, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jennifer J. Rhodes</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Jennifer J. Rhodes</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, Chief Legal Officer&#160;&amp; Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d905282dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BYLAWS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACADIA PHARMACEUTICALS INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A DELAWARE CORPORATION) </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BYLAWS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACADIA PHARMACEUTICALS INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A DELAWARE CORPORATION) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFICES
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;1.</B> <B>Registered Office</B>. The registered office of Acadia Pharmaceuticals Inc. (the
&#147;<B><I>Corporation</I></B>&#148;) in the State of Delaware and the name of the Corporation&#146;s registered agent at such address shall be as set forth in the certificate of incorporation of the Corporation (as the same may be amended and/or
restated from time to time, the &#147;<B><I>Certificate of Incorporation</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;2.</B> <B>Other
Offices</B>. The Corporation shall also have and maintain an office or principal place of business at such place as may be fixed by the Board of Directors of the Corporation (&#147;<B><I>Board of Directors</I></B>&#148;), and may also have offices
at such other places, both within and without the State of Delaware as the Board of Directors may from time to time determine or the business of the Corporation may require. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE
SEAL </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;3.</B> <B>Corporate Seal</B>. The Board of Directors may adopt a corporate seal. Said seal may be
used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCKHOLDERS&#146; MEETINGS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;4.</B> <B>Place Of Meetings</B>. Meetings of the stockholders of the Corporation may be held at such place, if
any, either within or without the State of Delaware, as may be determined from time to time by the Board of Directors (or its designee). The Board of Directors may, in its sole discretion, determine that the meeting shall not be held at any place,
but may instead be held solely by means of remote communication as provided under the General Corporation Law of the State of Delaware (the &#147;<B><I>DGCL</I></B>&#148;) and Section&nbsp;13 below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.</B> <B>Annual Meetings</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The annual meeting of the stockholders of the Corporation, for the purpose of election of directors and for such other business as
may properly come before it, shall be held on such date and at such time as may be designated from time to time by the Board of Directors (or its designee). Any annual meeting of stockholders previously scheduled by the Board of Directors may be
postponed, rescheduled or cancelled by the Board of Directors, or any director or officer of the Corporation to whom the Board of Directors delegates such authority, at any time </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
before or after notice of such meeting has been given to stockholders. Nominations of persons for election to the Board of Directors and proposals of other business to be considered by the
stockholders may be made at an annual meeting of stockholders: (i)&nbsp;pursuant to the Corporation&#146;s notice of meeting of stockholders (or any supplement thereto) given by or at the direction of the Board of Directors; (ii)&nbsp;by or at the
direction of the Board of Directors or a duly authorized committee thereof; or (iii)&nbsp;by any stockholder of the Corporation who was a stockholder of record at the time of giving the stockholder&#146;s notice provided for in Section&nbsp;5(b) of
these bylaws (as may be amended and/or restated from time to time, these &#147;<B><I>Bylaws</I></B>&#148;) and who is a stockholder of record at the time of the annual meeting of stockholders, who is entitled to vote at the meeting and who complied
with the notice procedures set forth in this Section&nbsp;5 of these Bylaws. Clause (iii)&nbsp;of this Section&nbsp;5(a) shall be the exclusive means for a stockholder to make nominations and submit other business before an annual meeting of
stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> At an annual meeting of stockholders, only such business shall be conducted as is a proper matter for
stockholder action under the DGCL, the Certificate of Incorporation and these Bylaws, and only such nominations shall be made and such business shall be conducted as shall have been properly brought before the annual meeting in accordance with the
procedures below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> For nominations for election as directors to be properly brought before an annual meeting by a stockholder
pursuant to clause (iii)&nbsp;of Section&nbsp;5(a) of these Bylaws, the stockholder must deliver written notice to the Secretary at the principal executive offices of the Corporation on a timely basis as set forth in Section&nbsp;5(b)(iii) of these
Bylaws and must update and supplement the information contained in such written notice on a timely basis as set forth in Section&nbsp;5(c) of these Bylaws. Such stockholder&#146;s notice shall set forth: (A)&nbsp;as to each nominee such stockholder
proposes to nominate at the meeting: (1)&nbsp;the name, age, business address and residence address of such nominee, (2)&nbsp;the principal occupation or employment of such nominee, (3)&nbsp;the class or series and number of shares of each class or
series of capital stock of the Corporation which are owned of record and beneficially by such nominee and list of any pledge of or encumbrances on such shares, (4)&nbsp;the date or dates on which such shares were acquired and the investment intent
of such acquisition, (5)&nbsp;the questionnaire, representation and agreement required by Section&nbsp;5(e), completed and signed by such proposed nominee, and (6)&nbsp;such other information concerning such nominee as would be required to be
disclosed in a proxy statement soliciting proxies for the election of such nominee as a director in an election contest (even if an election contest is not involved and whether or not proxies are being or will be solicited) or that is otherwise
required or provided to the Corporation to be disclosed pursuant to Section&nbsp;14 of the Securities Exchange Act of 1934, as amended (the &#147;<B><I>1934 Act</I></B>&#148;), and the rules and regulations promulgated thereunder (including such
person&#146;s written consent to being named in a proxy statement, associated proxy card and other filings as a nominee and to serving as a director if elected); and (B)&nbsp;all of the information required by Section&nbsp;5(b)(iv) of these Bylaws.
The Corporation may require any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation or to serve on any committee
or <FONT STYLE="white-space:nowrap">sub-committee</FONT> of the Board of Directors, in either case under any applicable stock exchange listing requirements, applicable law or the Policies (as defined below). The number of nominees a stockholder may
nominate for election at an annual meeting on its own behalf (or in the case of a stockholder giving the notice on behalf of a beneficial owner, the number of nominees a stockholder may nominate for election at an annual meeting on behalf of such
beneficial owner) shall not exceed the number of directors to be elected at such annual meeting. A stockholder may not designate any substitute or alternate nominees unless the stockholder provides timely notice of such substitute or alternate
nominee(s) in accordance with this Section&nbsp;5, in the case of an annual meeting, or Section&nbsp;6, in the case of a special meeting (and such notice contains all of the information, representations, questionnaires and certifications with
respect to such substitute or alternate nominee(s) that are required by these Bylaws with respect to nominees for director). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> For business other than nominations for election as directors to be properly
brought before an annual meeting by a stockholder pursuant to clause (iii)&nbsp;of Section&nbsp;5(a) of these Bylaws, the stockholder must deliver written notice to the Secretary at the principal executive offices of the Corporation on a timely
basis as set forth in Section&nbsp;5(b)(iii) of these Bylaws and must update and supplement the information contained in such written notice on a timely basis as set forth in Section&nbsp;5(c) of these Bylaws. Such stockholder&#146;s notice shall
set forth: (A)&nbsp;as to each matter such stockholder proposes to bring before the meeting: (1)&nbsp;a brief description of the business desired to be brought before the meeting, (2)&nbsp;the text of the proposal or business (including the text of
any resolutions proposed for consideration and in the event that such business includes a proposal to amend these Bylaws, the language of the proposed amendment), (3) the reasons for conducting such business at the meeting, and (4)&nbsp;any material
interest of any Proponent (as defined below) in such business (including any anticipated benefit of such business to any Proponent, which is material to any Proponent individually or to the Proponents in the aggregate other than solely as a result
of its or their ownership of the Corporation&#146;s capital stock); and (B)&nbsp;the information required by Section&nbsp;5(b)(iv) of these Bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> To be timely, the written notice required by Section&nbsp;5(b)(i) or 5(b)(ii) of these Bylaws must be received by the Secretary
at the principal executive offices of the Corporation not later than the close of business on the 90th day nor earlier than the close of business on the 120th day prior to the first anniversary of the immediately preceding year&#146;s annual
meeting; <I>provided, however</I>, that, subject to the last sentence of this Section&nbsp;5(b)(iii), in the event that the date of the annual meeting is advanced more than 30 days prior to or delayed by more than 70 days after the anniversary of
the preceding year&#146;s annual meeting, or if no annual meeting was held (or deemed to have been held), for notice by the stockholder to be timely, such stockholder&#146;s written notice must be so received by the Secretary not earlier than the
close of business on the 120th day prior to such annual meeting and not later than the close of business on the later of (A)&nbsp;the 90th day prior to such annual meeting or (B)&nbsp;the 10th day following the day on which public announcement of
the date of such meeting is first made. Notwithstanding the foregoing, in no event shall an adjournment or postponement (or the public announcement thereof) of an annual meeting for which notice has been given, or for which a public announcement of
the date of the meeting has been made by the Corporation, commence a new time period (or extend any time period) for the giving of a stockholder&#146;s notice as described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> The written notice required by Section&nbsp;5(b)(i) or 5(b)(ii) of these Bylaws shall also set forth, as of the date of the
notice and as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made and any affiliate who controls either of the foregoing stockholder or beneficial owner, directly or indirectly
(each, a &#147;<B><I>Proponent</I></B>&#148; and collectively, the &#147;<B><I>Proponents</I></B>&#148;): (A) the name and address of each Proponent (including, if applicable, the name and address that appear on the Corporation&#146;s books and
records); (B) the class, series and number of shares of each class or series of the capital stock of the Corporation that are, directly or indirectly, owned of record or beneficially (within the meaning of Rule
<FONT STYLE="white-space:nowrap">13d-3</FONT> under the 1934 Act) by each Proponent (<I>provided</I>, that for purposes of this Section&nbsp;5(b)(iv), such Proponent shall in all events be deemed to beneficially own all shares of any class or series
of capital stock of the Corporation as to which such Proponent or any of its affiliates or associates has a right to acquire beneficial ownership whether immediately or at any time in the future); (C) a description of any agreement, arrangement or
understanding (whether oral or in writing) with respect to such nomination or proposal (and/or the voting of shares of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
class or series of capital stock of the Corporation, other than a revocable proxy given in response to a proxy solicitation made to 10 or more persons) between or among any Proponent and any of
its affiliates or associates, and/or any other persons (including their names) including without limitation, any agreements, arrangements or understandings required to be disclosed pursuant to Item 5 or Item 6 of 1934 Act Schedule 13D if Schedule
13D were applicable, regardless of whether the requirement to file a Schedule 13D is applicable; (D)&nbsp;a representation that the Proponents are holders of record or beneficial owners, as the case may be, of shares of the Corporation at the time
of giving notice, will be entitled to vote at the meeting, and that such Proponent (or a qualified representative thereof) intends to appear at the meeting to nominate the person or persons specified in the notice (with respect to a notice under
Section&nbsp;5(b)(i) of these Bylaws) or to propose the business that is specified in the notice (with respect to a notice under Section&nbsp;5(b)(ii) of these Bylaws); (E) a representation whether any Proponent or any other participant (as defined
in Item 4 of Schedule 14A under the 1934 Act) will engage in a solicitation with respect to such nomination or proposal and, if so, the name of each participant in such solicitation and the amount of the cost of solicitation that has been and will
be borne, directly or indirectly, by each participant in such solicitation, and a representation as to whether the Proponents intend or are part of a group which intends (x)&nbsp;to deliver, or make available, a proxy statement and/or form of proxy
to holders of at least the percentage of the Corporation&#146;s voting shares required to approve or adopt the proposal or elect the nominee, (y)&nbsp;to otherwise solicit proxies or votes from stockholders in support of such proposal or nomination
and/or (z)&nbsp;to solicit proxies in support of any proposed nominee in accordance with Rule <FONT STYLE="white-space:nowrap">14a-19</FONT> promulgated under the 1934 Act; (F)&nbsp;a description of all Derivative Transactions (as defined below) by
each Proponent during the previous twelve (12)-month period, including the date of the transactions and the class, series and number of securities involved in, and the material economic or voting terms of, any such Derivative Transaction; (G)&nbsp;a
certification regarding whether each Proponent has complied with all applicable federal, state and other legal requirements in connection with such Proponent&#146;s acquisition of shares of capital stock or other securities of the Corporation and/or
such Proponent&#146;s acts or omissions as a stockholder or beneficial owner of the Corporation; and (H)&nbsp;any other information relating to each Proponent required to be disclosed in a proxy statement or other filings required to be made in
connection with solicitations of proxies for, as applicable, the proposal and/or for the election of directors in an election contest pursuant to and in accordance with Section&nbsp;14 of the 1934 Act and the rules and regulations promulgated
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> A stockholder providing the written notice required by Section&nbsp;5(b)(i) or (ii)&nbsp;of these Bylaws shall
update and supplement such notice in writing, if necessary, so that the information (other than the representations required by Section&nbsp;5(b)(iv)(E) of these Bylaws) provided or required to be provided in such notice is true and correct in all
material respects as of (i)&nbsp;the record date for the determination of stockholders entitled to notice of the meeting and (ii)&nbsp;the date that is five Business Days (as defined below) prior to the date of the meeting and, in the event of any
adjournment or postponement thereof, five Business Days prior to such adjourned or postponed meeting; <I>provided</I>, that no such update or supplement shall cure or affect the accuracy (or inaccuracy) of any representations made by any Proponent,
any of its affiliates or associates, or a nominee or the validity (or invalidity) of any nomination or proposal that failed to comply with this Section&nbsp;5 or is rendered invalid as a result of any inaccuracy therein. In the case of an update and
supplement pursuant to clause (i)&nbsp;of this Section&nbsp;5(c), such update and supplement must be received by the Secretary at the principal executive offices of the Corporation not later than five Business Days after the later of the record date
for the determination of stockholders entitled to notice of the meeting or the public announcement of such record date. In the case of an update and supplement pursuant to clause (ii)&nbsp;of this Section&nbsp;5(c), such update and supplement shall
be received by the Secretary at the principal executive offices of the Corporation not later than two Business Days prior to the date for the meeting, and, in the event of any adjournment or postponement thereof, two Business Days prior to such
adjourned or postponed meeting (or if there are fewer than two Business Days between the date for the meeting, or the date of the immediately preceding adjournment or postponement thereof, and the date for the adjourned or postponed meeting, not
later than the day prior to such adjourned or postponed meeting). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> In the event that the number of directors to be elected is increased and there is
no public announcement by the Corporation naming all of the nominees for election or specifying the size of the increased Board of Directors at least ten days before the last day a stockholder may deliver a notice of nomination in accordance with
Section&nbsp;5(b)(iii) of these Bylaws, a stockholder&#146;s notice required by Section&nbsp;5 of these Bylaws and which complies with the requirements in Section&nbsp;5(b)(i) of these Bylaws, other than the timing requirements in
Section&nbsp;5(b)(iii) of these Bylaws, shall also be considered timely, but only with respect to nominees for any new positions created by such increase, if it shall be received by the Secretary at the principal executive offices of the Corporation
not later than the close of business on the 10th day following the day on which the public announcement of the increase in the number of directors to be elected is first made by the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> To be eligible to be a nominee for election or <FONT STYLE="white-space:nowrap">re-election</FONT> as a director of the Corporation
pursuant to a nomination under clause (iii)&nbsp;of Section&nbsp;5(a) or clause (ii)&nbsp;of Section&nbsp;6(c), each Proponent must deliver (in accordance with the time periods prescribed for delivery of notice under Sections 5(b)(iii), 5(d) or
6(c), as applicable) to the Secretary at the principal executive offices of the Corporation a written questionnaire with respect to the background, qualifications, stock ownership and independence of such proposed nominee (in the form provided by
the Secretary within 10 days following a written request therefor by a stockholder of record) and a written representation and agreement (in the form provided by the Secretary within 10 days following written request therefor by a stockholder of
record) that such person (i)&nbsp;is not and will not become a party to (A)&nbsp;any agreement, arrangement or understanding (whether oral or in writing) with, and has not given any commitment or assurance to, any person or entity as to how such
person, if elected as a director of the Corporation, will act or vote on any issue or question (a &#147;<B><I>Voting Commitment</I></B>&#148;) that has not been disclosed in the questionnaire or (B)&nbsp;any Voting Commitment that could limit or
interfere with such person&#146;s ability to comply, if elected as a director of the Corporation, with such person&#146;s fiduciary duties under applicable law; (ii)&nbsp;is not and will not become a party to any agreement, arrangement or
understanding (whether oral or in writing) with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director of the
Corporation or a nominee that has not been disclosed in such questionnaire; (iii)<B></B>&nbsp;would be in compliance, if elected as a director of the Corporation, and will comply with, all applicable corporate governance, conflict of interest,
confidentiality and stock ownership and trading policies and guidelines of the Corporation that are publicly disclosed or which were provided by the Secretary with the written representation and agreement required by this Section&nbsp;5(e)
(together, the &#147;<B><I>Policies</I></B>&#148;); and (iv)&nbsp;if elected as a director of the Corporation, intends to serve the entire term until the next meeting at which such candidate would face
<FONT STYLE="white-space:nowrap">re-election.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> A person shall not be eligible for election or <FONT
STYLE="white-space:nowrap">re-election</FONT> as a director, unless the person is nominated, in the case of an annual meeting, in accordance with clause (ii)&nbsp;or (iii) of Section&nbsp;5(a) of these Bylaws and in accordance with the procedures
set forth in Section&nbsp;5(b), Section&nbsp;5(c), Section&nbsp;5(d), Section&nbsp;5(e) and this Section&nbsp;5(f), as applicable, or in the case of a special meeting, in accordance with Section&nbsp;6(c) of these Bylaws and the requirements
thereof. Only such business shall be conducted at any annual meeting of the stockholders of the Corporation as shall have been brought before the meeting in accordance with Section&nbsp;5(a) and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in accordance with the procedures set forth in Section&nbsp;5(b), Section&nbsp;5(c) and this Section&nbsp;5(f), as applicable. Unless otherwise required by applicable law, in the event that any
Proponent (i)&nbsp;provides notice pursuant to Rule <FONT STYLE="white-space:nowrap">14a-19(b)</FONT> promulgated under the 1934 Act with respect to one or more proposed nominees and (ii)&nbsp;subsequently (x) fails to comply with the requirements
of Rule <FONT STYLE="white-space:nowrap">14a-19</FONT> promulgated under the 1934 Act (or fails to timely provide reasonable evidence sufficient to satisfy the Corporation that such Proponent has met the requirements of Rule <FONT
STYLE="white-space:nowrap">14a-19(a)(3)</FONT> promulgated under the 1934 Act in accordance with the next sentence) or (y)&nbsp;fails to inform the Corporation that they no longer plan to solicit proxies in accordance with the requirements of Rule <FONT
STYLE="white-space:nowrap">14a-19</FONT> under the 1934 Act by delivering a written notice to the Secretary at the principal executive offices of the Corporation within two (2)&nbsp;Business Days after the occurrence of such change, then the
nomination of each such proposed nominee shall be disregarded (and such nominee disqualified from standing for election or <FONT STYLE="white-space:nowrap">re-election),</FONT> notwithstanding that the nominee is included (as applicable) as a
nominee in the Corporation&#146;s proxy statement, notice of meeting or other proxy materials for any stockholder meeting (or any supplement thereto) and notwithstanding that proxies or votes in respect of the election of such proposed nominees may
have been received by the Corporation (which proxies and votes shall be disregarded). If any Proponent provides notice pursuant to Rule <FONT STYLE="white-space:nowrap">14a-19(b)</FONT> promulgated under the 1934 Act, such Proponent shall deliver to
the Corporation, no later than five (5)&nbsp;Business Days prior to the applicable meeting, reasonable evidence sufficient to demonstrate that it has met the requirements of Rule <FONT STYLE="white-space:nowrap">14a-19(a)(3)</FONT> promulgated under
the 1934 Act. The nomination of any person whose name is included (as applicable) as a nominee in the Corporation&#146;s proxy statement, notice of meeting or other proxy materials for any stockholder meeting (or any supplement thereto) as a result
of any notice provided by any Proponent pursuant to Rule <FONT STYLE="white-space:nowrap">14a-19(b)</FONT> promulgated under the 1934 Act with respect to such proposed nominee and whose nomination is not made by or at the direction of the Board of
Directors or any authorized committee thereof shall not be deemed (for purposes of clause (i)&nbsp;of Section&nbsp;5(a) or otherwise) to have been made pursuant to the Corporation&#146;s notice of meeting (or any supplement thereto) and any such
nominee may only be nominated by a Proponent pursuant to clause (iii)&nbsp;of Section&nbsp;5(a) and, in the case of a special meeting of stockholders, pursuant to and to the extent permitted under Section&nbsp;6(c). Except as otherwise required by
applicable law, and subject to the supervision, direction and control of the Board of Directors, the chairperson of the meeting shall have the power and duty to determine whether a nomination for election as a director or any business proposed to be
brought before the meeting was made, or proposed, as the case may be, in accordance with the procedures and requirements set forth in these Bylaws (including, without limitation, compliance with Rule <FONT STYLE="white-space:nowrap">14a-19</FONT>
promulgated under the 1934 Act) and, if any proposed nomination or business is not in compliance with these Bylaws, or the Proponent does not act in accordance with the representations required in this Section&nbsp;5, to declare that such proposal
or nomination shall not be presented for stockholder action at the meeting and shall be disregarded (and such nominee disqualified from standing for election or <FONT STYLE="white-space:nowrap">re-election),</FONT> or that such business shall not be
transacted, notwithstanding that such proposal or nomination is set forth in (as applicable) the Corporation&#146;s proxy statement, notice of meeting or other proxy materials and notwithstanding that proxies or votes in respect of such nomination
or such business may have been solicited or received. Notwithstanding the foregoing provisions of this Section&nbsp;5, unless otherwise required by applicable law, if the stockholder (or a qualified representative of the stockholder) does not appear
at the annual meeting of stockholders of the Corporation to present a nomination or proposed business, such nomination shall be disregarded (and such nominee disqualified from standing for election or
<FONT STYLE="white-space:nowrap">re-election)</FONT> and such proposed business shall not be transacted, notwithstanding that such nomination or proposed business is set forth in (as applicable) the Corporation&#146;s proxy statement, notice of
meeting or other proxy materials and notwithstanding that proxies or votes in respect of such vote may have been solicited or received by the Corporation. For purposes of this Section&nbsp;5, to be considered a qualified representative of the
stockholder, a person must be a duly authorized officer, manager, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
trustee or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as
proxy at the meeting of stockholders, and such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, shall be provided to the Secretary of the Corporation at least five Business Days prior to the
meeting of stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> For purposes of Sections 5 and 6 of these Bylaws, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> &#147;<B><I>public announcement</I></B>&#148; shall mean disclosure in a press release reported by the Dow Jones News Service,
Associated Press, Business Wire, GlobeNewswire or comparable national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Section&nbsp;13, 14 or 15(d) of the 1934 Act or by such
other means reasonably designed to inform the public or security holders in general of such information, including, without limitation, posting on the Corporation&#146;s investor relations website; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> &#147;<B><I>affiliates</I></B>&#148; and &#147;<B><I>associates</I></B>&#148; shall have the meanings set forth in Rule 405 under
the Securities Act of 1933, as amended (the &#147;<B><I>1933 Act</I></B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> &#147;<B><I>Business Day</I></B>&#148;
means any day other than Saturday, Sunday or a day on which banks are closed in New York City, New York; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> &#147;<B><I>close
of business</I></B>&#148; means 6:00 p.m. local time at the principal executive offices of the Corporation on any calendar day, whether or not the day is a Business Day; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> &#147;<B><I>Derivative Transaction</I></B>&#148; means any agreement, arrangement, interest or understanding entered into by, or
on behalf or for the benefit of, any Proponent or any of its affiliates or associates, whether record or beneficial: (A)&nbsp;the value of which is derived in whole or in part from the value of any class or series of shares or other securities of
the Corporation; (B)&nbsp;that otherwise provides any direct or indirect opportunity to gain or share in any gain derived from a change in the value of securities of the Corporation; (C)&nbsp;the effect or intent of which is to mitigate loss, manage
risk or benefit from changes in value or price with respect to any securities of the Corporation; or (D)&nbsp;that provides the right to vote (other than a revocable proxy given in response to a proxy solicitation made to 10 or more persons) or
increase or decrease the voting power of, such Proponent, or any of its affiliates or associates, directly or indirectly, with respect to any securities of the Corporation, which agreement, arrangement, interest or understanding may include, without
limitation, any option, warrant, debt position, note, bond, convertible security, swap, stock appreciation or similar right, short position, profit interest, hedge, right to dividends, voting agreement, performance-related fee or arrangement to
borrow or lend shares (whether or not subject to payment, settlement, exercise or conversion in any such class or series), and any proportionate interest of such Proponent in the securities of the Corporation held by any general or limited
partnership, or any limited liability company, of which such Proponent is, directly or indirectly, a general partner or managing member. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;6.</B> <B>Special Meetings</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Special meetings of the stockholders of the Corporation may be called, for any purpose or purposes as is a proper matter for
stockholder action under Delaware law, by (i)&nbsp;the Chairperson of the Board of Directors, (ii)&nbsp;the Chief Executive Officer, or (iii)&nbsp;the Board of Directors pursuant to a resolution adopted by a majority of the total number of
authorized directors (whether or not there exist any vacancies in previously authorized directorships at the time any such resolution is presented to the Board of Directors for adoption). Any special meeting of stockholders previously scheduled by
the Board of Directors may be postponed, rescheduled or cancelled by the Board of Directors, or any director or officer to whom the Board of Directors has delegated such authority, at any time before or after notice of such meeting has been given to
stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> The Board of Directors (or its designee) shall determine the time and place of
any special meeting. Upon determination of the time and place, if any, of the meeting, the Secretary of the Corporation shall cause notice to be given to the stockholders entitled to vote, in accordance with the provisions of Section&nbsp;7 of these
Bylaws. Nothing contained in this paragraph (b)&nbsp;shall be construed as limiting, fixing, or affecting the time when a meeting of stockholders called by action of the Board of Directors may be held. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant
to the Corporation&#146;s notice of meeting. Nominations of persons for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected (i)&nbsp;by or at the direction of the Board of
Directors or a duly authorized committee thereof or (ii)&nbsp;by any stockholder of the Corporation who is a stockholder of record at the time of giving notice provided for in this paragraph and who is a stockholder of record at the time of the
special meeting, who is entitled to vote at the meeting and who complies with Sections 5(b)(i), 5(b)(iv), 5(c), 5(e) and 5(f). The number of nominees a stockholder may nominate for election at a special meeting on its own behalf (or in the case of a
stockholder giving the notice on behalf of a beneficial owner, the number of nominees a stockholder may nominate for election at a special meeting on behalf of such beneficial owner) shall not exceed the number of directors to be elected at such
special meeting. In the event the Corporation calls a special meeting of stockholders for the purpose of submitting a proposal to stockholders for the election of one or more directors, any such stockholder of record entitled to vote in such
election of directors may nominate a person or persons (as the case may be), for election to such position(s) as specified in the Corporation&#146;s notice of meeting, if written notice setting forth the information required by Sections 5(b)(i) and
5(b)(iv) of these Bylaws shall be received by the Secretary at the principal executive offices of the Corporation not earlier than the close of business on the 120<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day prior to such special
meeting and not later than the close of business on the later of (i)&nbsp;the 90<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day prior to such meeting or (ii)&nbsp;the 10th day following the day on which the Corporation first makes a
public announcement of the date of the special meeting at which directors are to be elected. The stockholder shall also update and supplement such information as required under Section&nbsp;5(c) of these Bylaws. In no event shall an adjournment or a
postponement (or the public announcement thereof) of a special meeting for which notice has been given, or for which a public announcement of the date of the meeting has been made by the Corporation, commence a new time period (or extend any time
period) for the giving of a stockholder&#146;s notice as described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> A person shall not be eligible for election or <FONT
STYLE="white-space:nowrap">re-election</FONT> as a director at the special meeting unless the person is nominated either in accordance with clause (i)&nbsp;or clause (ii)&nbsp;of Section&nbsp;6(c). Except as otherwise required by applicable law, and
subject to the supervision, direction and control of the Board of Directors, the chairperson of the meeting shall have the power and duty to determine whether a nomination was made in accordance with the procedures and requirements set forth in
these Bylaws and, if any proposed nomination is not in compliance with these Bylaws (including, without limitation, compliance with Rule <FONT STYLE="white-space:nowrap">14a-19</FONT> under the 1934 Act), or if the Proponent does not act in
accordance with the representations required in Section&nbsp;5, to declare that such nomination shall not be presented for stockholder action at the meeting and shall be disregarded (and such nominee disqualified from standing for election or <FONT
STYLE="white-space:nowrap">re-election),</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
notwithstanding that such nomination is set forth in (as applicable) the Corporation&#146;s proxy statement, notice of meeting or other proxy materials and notwithstanding that proxies or votes
in respect of such nomination may have been solicited or received. Notwithstanding the foregoing provisions of this Section&nbsp;6, unless otherwise required by applicable law, if the stockholder (or a qualified representative of the stockholder
(meeting the requirements specified in Section&nbsp;5(f))) does not appear at the special meeting of stockholders of the Corporation to present a nomination, such nomination shall be disregarded (and such nominee disqualified from standing for
election or <FONT STYLE="white-space:nowrap">re-election),</FONT> notwithstanding that the nomination is set forth (as applicable) in the Corporation&#146;s proxy statement, notice of meeting or other proxy materials and notwithstanding that proxies
or votes in respect of such nomination may have been solicited or received by the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> In addition to the requirements
of Sections 5 and 6, a stockholder must comply with all applicable requirements of the 1934 Act and the rules and regulations promulgated thereunder with respect to the matters set forth in Sections 5 and 6, and any failure to comply with such
requirements shall be deemed a failure to comply with Sections 5 or 6, as applicable; <I>provided</I>, <I>however</I>, that, to the fullest extent not prohibited by applicable law, any references in these Bylaws to the 1934 Act or the rules and
regulations promulgated thereunder are not intended to and shall not limit the requirements applicable to proposals and/or nominations to be considered pursuant to Sections 5(a)(iii) and 6(c). Nothing in these Bylaws shall be deemed to affect any
rights of holders of any class or series of preferred stock to nominate and elect directors pursuant to and to the extent provided in any applicable provision of the Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;7.</B> <B>Notice Of Meetings</B>. Except as otherwise provided by applicable law, the Certificate of
Incorporation or these Bylaws, notice of each meeting of stockholders shall be given not less than 10 nor more than 60 days before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining the
stockholders entitled to notice of such meeting. Such notice shall specify the date, time and place, if any, of the meeting, the record date for determining stockholders entitled to vote at the meeting, if such record date is different from the
record date for determining stockholders entitled to notice of the meeting, and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at any such meeting, and, in the case
of special meetings, the purpose or purposes of the meeting. Notice shall be deemed given as provided in Section&nbsp;232 of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;8.</B> <B>Quorum and Vote Required</B>. At all meetings of stockholders, except where otherwise required by law
or by the Certificate of Incorporation, or by these Bylaws, the presence, in person, by remote communication, if applicable, or by proxy, of the holders of a majority of the voting power of the outstanding shares of stock entitled to vote at the
meeting shall constitute a quorum for the transaction of business. The stockholders present at a duly called or convened meeting, at which a quorum is present, may continue to transact business until adjournment, notwithstanding the withdrawal of
enough stockholders to leave less than a quorum. Unless a different or minimum vote is provided by law or by applicable stock exchange rules, or by the Certificate of Incorporation or these Bylaws, in which case such different or minimum vote shall
be the applicable vote on the matter, in all matters other than the election of directors, the affirmative vote of a majority of the votes cast on such matter, voting affirmatively or negatively (excluding abstentions and broker <FONT
STYLE="white-space:nowrap">non-votes)</FONT> shall be the act of the stockholders. Except as otherwise required by law, the Certificate of Incorporation or these Bylaws, directors shall be elected by a plurality of the votes of the shares present in
person, by remote communication, if applicable, or represented by proxy at the meeting and entitled to vote in the election of directors. Where a separate vote by a class or classes or series is required, except as required by law or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by the Certificate of Incorporation or these Bylaws, the holders of a majority of the voting power of the outstanding shares of such class or classes or series, present in person, by remote
communication, if applicable, or represented by proxy, shall constitute a quorum entitled to take action with respect to that vote on that matter. Unless a different or minimum vote is provided by law or by the Certificate of Incorporation or these
Bylaws or any applicable stock exchange rules, in which case such different or minimum vote shall be the applicable vote on the matter, the affirmative vote of the holders of a majority (or plurality, in the case of the election of directors) of the
votes cast on such matter, voting affirmatively or negatively (excluding abstentions and broker <FONT STYLE="white-space:nowrap">non-votes)</FONT> shall be the act of such class or classes or series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;9.</B> <B>Adjournment And Notice Of Adjourned Meetings</B>. Any meeting of stockholders, whether annual or
special, may be adjourned from time to time either by the chairperson of the meeting or by the stockholders by the affirmative vote of a majority of the votes cast, voting affirmatively or negatively (excluding abstentions and broker <FONT
STYLE="white-space:nowrap">non-votes).</FONT> When a meeting is adjourned to another time or place, if any, (including an adjournment taken to address a technical failure to convene or continue a meeting using remote communication) notice need not
be given of the adjourned meeting if the time and place, if any, thereof and the means of remote communication, if any, by which stockholders and proxyholders may be deemed present in person and may vote at such meeting are announced at the meeting
at which the adjournment is taken or are (i)&nbsp;displayed, during the time scheduled for the meeting, on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means of remote communication or
(ii)&nbsp;set forth in the notice of meeting given in accordance with Section&nbsp;7. At the adjourned meeting, the Corporation may transact any business which have been transacted at the original meeting. If the adjournment is for more than 30
days, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. If after the adjournment a new record date for determination of stockholders entitled to vote is fixed for the adjourned meeting,
the Board of Directors shall fix as the record date for determining stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting, and
shall give notice of the adjourned meeting to each stockholder of record entitled to vote at such adjourned meeting as of the record date so fixed for notice of such adjourned meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;10.</B> <B>Voting Rights</B>. For the purpose of determining those stockholders entitled to vote at any meeting
of the stockholders or adjournment thereof, except as otherwise provided by applicable law, only persons in whose names shares stand on the stock records of the Corporation on the record date shall be entitled to vote<B> </B>at any meeting of
stockholders. Each stockholder entitled to vote at a meeting of stockholders may authorize another person or persons to act for such stockholder by proxy. No proxy shall be voted after 3 years from its date of creation unless the proxy provides for
a longer period. Voting at meetings of stockholders need not be by written ballot. Any stockholder directly or indirectly soliciting proxies from other stockholders must use a proxy card color other than white, which shall be reserved for the
exclusive use by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;11.</B> <B>Joint Owners Of Stock</B>. If shares or other
securities having voting power stand of record in the names of 2 or more persons, whether fiduciaries, members of a partnership, joint tenants, tenants in common, tenants by the entirety, or otherwise, or if 2 or more persons have the same fiduciary
relationship respecting the same shares, unless the Secretary is given written notice to the contrary and is furnished with a copy of the instrument or order appointing them or creating the relationship wherein it is so provided, their acts with
respect to voting shall have the following effect: (a)&nbsp;if only one votes, his act binds all; (b)&nbsp;if more than one votes, the act of the majority so voting binds all; (c)&nbsp;if more than one votes, but the vote is evenly split on any
particular matter, each faction may vote the securities in question proportionally, or may apply to the Delaware Court of Chancery for relief as provided in the DGCL, Section&nbsp;217(b). If the instrument filed with the Secretary shows that any
such tenancy is held in unequal interests, a majority or even-split for the purpose of subsection (c)&nbsp;shall be a majority or even-split in interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;12.</B> <B>List </B><B>Of</B><B> Stockholders</B>. The
Corporation shall prepare, at least 10 days before every meeting of stockholders, a complete list of the stockholders entitled to vote at said meeting, arranged in alphabetical order, showing the address of each stockholder and the number of shares
registered in the name of each stockholder; <I>provided</I>, <I>however</I>, if the record date for determining the stockholders entitled to vote is less than ten days before the meeting date, the list shall reflect all of the stockholders entitled
to vote as of the tenth day before the meeting date. Nothing in this Section&nbsp;12 shall require the Corporation to include electronic mail addresses or other electronic contact information on such list. Such list shall be open to the examination
of any stockholder, for any purpose germane to the meeting for a period of ten days ending on the day before the meeting date: (a)&nbsp;on a reasonably accessible electronic network, provided that the information required to gain access to such list
is provided with the notice of the meeting, or (b)&nbsp;during ordinary business hours, at the principal place of business of the Corporation. In the event that the Corporation determines to make the list available on an electronic network, the
Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;13. Remote Communication; Delivery to the Corporation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> If authorized by the Board of Directors in its sole discretion, and subject to such guidelines and procedures as the Board of
Directors may adopt, stockholders and proxyholders not physically present at a stockholder meeting may, by means of remote communication: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> participate in a meeting of stockholders; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> be deemed present in person and vote at a meeting of stockholders whether such meeting is to be held at a designated place or
solely by means of remote communication, provided that (i)&nbsp;the Corporation shall implement reasonable measures to verify that each person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder or
proxyholder, (ii)&nbsp;the Corporation shall implement reasonable measures to provide such stockholders and proxyholders a reasonable opportunity to participate in the meeting and to vote on matters submitted to the stockholders, including an
opportunity to read or hear the proceedings of the meeting substantially concurrently with such proceedings, and (iii)&nbsp;if any stockholder or proxyholder votes or takes other action at the meeting by means of remote communication, a record of
such vote or other action shall be maintained by the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Whenever Sections 5 or 6 require one or more persons
(including a record or beneficial owner of capital stock) to deliver a document or information to the Corporation or any officer, employee or agent thereof (including any notice, request, questionnaire, revocation, representation or other document
or agreement), such document or information shall be in writing exclusively (and not in an electronic transmission) and shall be delivered exclusively by hand (including, without limitation, overnight courier service) or by certified or registered
mail, return receipt requested and the Corporation shall not be required to accept delivery of any document not in such written form or so delivered. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;14.</B> <B>Organization</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> If no chairperson of the meeting of stockholders is so designated, then the Chairperson of the Board of Directors, or if no
Chairperson has been appointed, is absent or refuses to act, the Chief Executive Officer, or if no Chief Executive Officer is then serving or the Chief Executive Officer is absent or refuses to act, the President, or, if the President is absent or
refuses to act, a chairperson of the meeting chosen by the stockholders by the affirmative vote of a majority of the votes cast, voting affirmatively or negatively (excluding abstentions and broker <FONT STYLE="white-space:nowrap">non-votes),</FONT>
shall act as chairperson of the meeting of stockholders. A person designated by the Board of Directors shall act as secretary of the meeting. If no secretary of the meeting is designated, then the Secretary, or, in the Secretary&#146;s absence, an
Assistant Secretary or other officer or other person directed to do so by the chairperson of the meeting, shall act as secretary of the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> The Board of Directors of the Corporation shall be entitled to make such rules or regulations for the conduct of meetings of
stockholders as it shall deem necessary, appropriate or convenient. Subject to such rules and regulations of the Board of Directors, if any, the chairperson of the meeting shall have the right and authority to convene and (for any or no reason) to
recess and/or adjourn the meeting, to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairperson, are necessary, appropriate or convenient for the proper conduct of the meeting, including,
without limitation, establishing an agenda or order of business for the meeting, rules and procedures for maintaining order at the meeting and the safety of those present, limitations on participation in such meeting to stockholders of record of the
Corporation and their duly authorized and constituted proxies and such other persons as the chairperson shall permit, restrictions on entry to the meeting after the time fixed for the commencement thereof, limitations on the time allotted to
questions or comments by participants and regulation of the opening and closing of the polls for balloting on matters which are to be voted on by ballot. The date and time of the opening and closing of the polls for each matter upon which the
stockholders will vote at the meeting shall be announced at the meeting. Unless and to the extent determined by the Board of Directors or the chairperson of the meeting, meetings of stockholders shall not be required to be held in accordance with
rules of parliamentary procedure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> The Corporation may and shall, if required by applicable law, in advance of any meeting of
stockholders, appoint one or more inspectors to act at the meeting and make a written report thereof. The Corporation may designate one or more persons as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate
is able to act at a meeting of stockholders, the chairperson of the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of the duties of inspector, shall take and sign an oath
faithfully to execute the duties of inspector with strict impartiality and according to the best of such inspector&#146;s ability. The inspectors shall: (1)&nbsp;ascertain the number of shares outstanding and the voting power of each;
(2)&nbsp;determine the shares represented at a meeting and the validity of proxies and ballots; (3)&nbsp;count all votes and ballots; (4)&nbsp;determine and retain for a reasonable period a record of the disposition of any challenges made to any
determination by the inspectors; and (5)&nbsp;certify their determination of the number of shares represented at the meeting, and their count of all votes and ballots. The inspectors may appoint or retain other persons or entities to assist the
inspectors in the performance of the duties of the inspectors. In determining the validity and counting of proxies and ballots, the inspectors shall be limited to an examination of the proxies, any envelopes submitted with those proxies, any
information provided in accordance with Sections 211(e) or 212(c)(2) of the DGCL, or any information provided pursuant to Sections 211(a)(2)b.(i) or (iii)&nbsp;of the DGCL, ballots and the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
regular books and records of the Corporation, except that the inspectors may consider other reliable information for the limited purpose of reconciling proxies and ballots submitted by or on
behalf of banks, brokers, their nominees or similar persons which represent more votes than the holder of a proxy is authorized by the record owner to cast or more votes than the stockholder holds of record. If the inspectors consider other reliable
information for the limited purpose permitted herein, the inspectors at the time they make their certification pursuant to Section&nbsp;231(b)(5) of the DGCL shall specify the precise information considered by them including the person or persons
from whom they obtained the information, when the information was obtained, the means by which the information was obtained and the basis for the inspectors&#146; belief that such information is accurate and reliable. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTORS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;15.</B> <B>Number And Term Of Office</B>. The authorized number of directors of the Corporation shall
be fixed in accordance with the Certificate of Incorporation. Directors need not be stockholders unless so required by the Certificate of Incorporation. If for any reason, the directors shall not have been elected at an annual meeting, they may be
elected as soon thereafter as convenient at a special meeting of the stockholders called for that purpose in the manner provided in these Bylaws. The terms of directors shall be as set forth in the Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;16.</B> <B>Powers</B>. The business and affairs of the Corporation shall be managed by or under the direction of
the Board of Directors, except as may be otherwise provided by the Certificate of Incorporation or the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;17.</B> <B>Classes of Directors</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances,
the directors shall be divided into three classes designated as Class&nbsp;I, Class&nbsp;II and Class&nbsp;III, respectively. At each annual meeting of stockholders, directors shall be elected for a full term of three years to succeed the directors
of the class whose terms expire at such annual meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> No stockholder entitled to vote at an election for directors may
cumulate votes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Notwithstanding the foregoing provisions of this section, each director shall serve until his successor is
duly elected and qualified or until his earlier death, resignation or removal. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;18.</B> <B>Vacancies</B>. Vacancies and newly created directorships on the Board of Directors shall be filled as
set forth in the Certificate of Incorporation, except as otherwise required by applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;19.</B> <B>Resignation</B>. Any director may resign at any
time by delivering such director&#146;s notice in writing or by electronic transmission to the Secretary or the Board of Directors. Such resignation shall take effect at the time of delivery of the notice or at any later time specified therein.
Acceptance of such resignation shall not be necessary to make it effective. When one or more directors shall resign from the Board of Directors, effective at a future date, a majority of the directors then in office, including those who have so
resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective, and each director so chosen shall hold office for the unexpired portion of the term of the
director whose place shall be vacated and until such director&#146;s successor shall have been duly elected and qualified or until such director&#146;s earlier death, resignation or removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;20.</B> <B>Removal</B>. Directors shall be removed as set forth in the Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;21.</B> <B>Meetings</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Regular Meetings</B>. Unless otherwise restricted by the Certificate of Incorporation, regular meetings of the Board of
Directors may be held at any time or date and at any place, if any, within or without the State of Delaware which has been designated by the Board of Directors and publicized among all directors, either orally or in writing, by telephone, including
a voice-messaging system or other system designed to record and communicate messages, facsimile, or by electronic mail or other electronic means. No further notice shall be required for regular meetings of the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Special Meetings</B>. Unless otherwise restricted by the Certificate of Incorporation, special meetings of the Board of
Directors may be held at any time and place, if any, within or without the State of Delaware as designated and called by the Chairperson of the Board of Directors, the Chief Executive Officer or by a majority of the directors then in office. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Meetings by Electronic Communications Equipment</B>. Any member of the Board of Directors, or of any committee thereof, may
participate in a meeting by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting by such means shall constitute presence in
person at such meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Notice of Special Meetings</B>. Notice of the time and place, if any, of all special meetings of
the Board of Directors shall be given orally or in writing, by telephone, including a voice messaging system or other system or technology designed to record and communicate messages, or by electronic mail or other means of electronic transmission
at least 24 hours before the date and time of the meeting. If notice is sent by U.S. mail, it shall be sent by first class mail, postage prepaid, at least 3 days before the date of the meeting. Neither the business to be transacted at, nor the
purpose of, any special meeting of the Board of Directors need be specified in any such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;22.</B>
<B>Quorum And Voting</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Except as otherwise required by the DGCL, the Certificate of Incorporation or these Bylaws, a quorum
of the Board of Directors shall consist of a majority of the authorized number of directors fixed from time to time by the Board of Directors in accordance with the Certificate of Incorporation; <I>provided, however</I>, at any meeting whether a
quorum be present or otherwise, a majority of the directors present may adjourn the meeting to another time, without notice other than by announcement at the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> At each meeting of the Board of Directors at which a quorum is present, all questions and business shall be determined by the
affirmative vote of a majority of the directors present, unless a different vote be required by applicable law, the Certificate of Incorporation or these Bylaws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;23.</B> <B>Action Without Meeting</B>. Unless otherwise
restricted by the Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all members of the Board of
Directors or committee, as the case may be, consent thereto in writing or by electronic transmission. After an action is taken, such consent or consents shall be filed with the minutes of proceedings of the Board of Directors or committee. Such
filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;24.</B> <B>Fees And Compensation</B>. Unless otherwise restricted by the Certificate of Incorporation or these
Bylaws, the Board of Directors, or any duly authorized committee thereof, shall have the authority to fix the compensation, including fees and reimbursement of expenses, of directors for services to the Corporation in any capacity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;25.</B> <B>Committees</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Executive Committee</B>. The Board of Directors may appoint from time to time an Executive Committee to consist of one or more
members of the Board of Directors. The Executive Committee, to the extent permitted by applicable law and provided in the resolution of the Board of Directors shall have and may exercise all the powers and authority of the Board of Directors in the
management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers which may require it; but no such committee shall have the power or authority in reference to (i)&nbsp;approving or
adopting, or recommending to the stockholders, any action or matter (other than the election or removal of directors) expressly required by the DGCL to be submitted to stockholders for approval, or (ii)&nbsp;adopting, amending or repealing any bylaw
of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Other Committees</B>. The Board of Directors may, from time to time, appoint such other committees as
may be permitted by applicable law. Such other committees appointed by the Board of Directors shall consist of one or more members of the Board of Directors and shall have such powers and perform such duties as may be prescribed by the resolution or
resolutions creating such committees, but in no event shall any such committee have the powers denied to the Executive Committee in these Bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Term</B>. The Board of Directors, subject to any requirements of any outstanding series of Preferred Stock and the provisions of
subsections (a)&nbsp;or (b) of this Section&nbsp;25, may at any time increase or decrease the number of members of a committee or terminate the existence of a committee. The membership of a committee member shall terminate on the date of such
committee member&#146;s death, such person&#146;s resignation from the committee or on such date that the committee member, for any reason, is no longer a member of the Board of Directors. The Board of Directors may at any time for any reason remove
any individual committee member and the Board of Directors may fill any committee vacancy created by death, resignation, removal or increase in the number of members of the committee. The Board of Directors may designate one or more directors as
alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee, and, in addition, in the absence or disqualification of any member of a committee, the member or members thereof present at any
meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Meetings</B>. Unless the Board of Directors shall otherwise provide, regular
meetings of the Executive Committee or any other committee appointed pursuant to this Section&nbsp;25 shall be held at such times and places, if any, as are determined by the Board of Directors, or by any such committee, and when notice thereof has
been given to each member of such committee, no further notice of such regular meetings need be given thereafter. Special meetings of any such committee may be held at such place, if any, which has been determined from time to time by such
committee, and may be called by any director who is a member of such committee, upon notice to the members of such committee of the time and place, if any, of such special meeting given in the manner provided for the giving of notice to members of
the Board of Directors of the time and place of special meetings of the Board of Directors. Unless otherwise provided by the Board of Directors in the resolutions authorizing the creation of the committee, the presence of at least a majority of the
members of the committee then serving shall be necessary to constitute a quorum unless the committee shall consist of one or two members, in which event one member shall constitute a quorum; and all matters shall be determined by the affirmative
vote of a majority of the members present at a meeting of the committee at which a quorum is present. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;26.</B> <B>Organization</B>. At every meeting of the directors, the Chairperson of the Board of Directors shall
act as chairperson of the meeting. If a Chairperson has not been appointed or is absent, the Chief Executive Officer (if a director), or, if no Chief Executive Officer is then serving or the Chief Executive Officer is absent, the President (if a
director), or, in the absence of any such person, a chairperson of the meeting chosen by a majority of the directors present, shall preside over the meeting. The Secretary, or in the Secretary&#146;s absence, any Assistant Secretary or other
officer, director or other person directed to do so by the person presiding over the meeting, shall act as secretary of the meeting. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFICERS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;27.</B> <B>Officers Designated</B>. The officers of the Corporation shall include, if and when
designated by the Board of Directors, the Chairperson of the Board of Directors, The Chief Executive Officer, the President, one or more Vice Presidents, the Secretary, the Chief Financial Officer, the Treasurer and the Controller. The Board of
Directors may also appoint one or more Assistant Secretaries, Assistant Treasurers, Assistant Controllers and such other officers and agents with such powers and duties as it shall deem appropriate or necessary. The Board of Directors may assign
such additional titles to one or more of the officers as it shall deem appropriate. Any one person may hold any number of offices of the Corporation at any one time unless specifically prohibited therefrom by applicable law, the Certificate of
Incorporation or these Bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;28.</B> <B>Tenure And Duties Of Officers</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>General</B>. All officers shall hold office at the pleasure of the Board of Directors and until their successors shall have been
duly elected and qualified, subject to such officer&#146;s earlier death, resignation or removal. Any officer elected or appointed by the Board of Directors may be removed at any time by the Board of Directors. If the office of any officer becomes
vacant for any reason, the vacancy may be filled by the Board of Directors or by a committee thereof to which the Board of Directors has delegated such responsibility or, if so authorized by the Board of Directors, by the Chief Executive Officer or
another officer of the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Duties of Chairperson of the Board of Directors</B>. The Chairperson of the
Board of Directors, when present, shall preside at all meetings of the stockholders and the Board of Directors in accordance with Section&nbsp;26. The Chairperson of the Board of Directors shall perform other duties commonly incident to the office
and shall also perform such other duties and have such other powers, as the Board of Directors shall designate from time to time. If there is no Chief Executive Officer, unless otherwise determined by the Board of Directors, then the Chairperson of
the Board of Directors shall also serve as the Chief Executive Officer of the Corporation and shall have the powers and duties prescribed in paragraph (c)&nbsp;of this Section&nbsp;28. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Duties of Chief Executive Officer</B>. The Chief Executive Officer shall preside, if a director, at all meetings of the Board of
Directors, unless a Chairperson of the Board of Directors has been appointed and is present. The Chief Executive Officer of the Corporation shall be the chief executive officer of the Corporation and shall, subject to the supervision, direction and
control of the Board of Directors, have the general powers and duties of supervision, direction, management and control of the business and officers of the Corporation as are customarily associated with the position of Chief Executive Officer. To
the extent that a Chief Executive Officer has been appointed and no President has been appointed, all references in these Bylaws to the President shall be deemed references to the Chief Executive Officer. The Chief Executive Officer shall perform
other duties commonly incident to the office and shall also perform such other duties and have such other powers, as the Board of Directors shall designate from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Duties of the President</B>. The President shall preside, if a director, at all meetings of the stockholders and at all meetings
of the Board of Directors, unless the Chairperson of the Board of Directors or the Chief Executive Officer has been appointed and is present and willing to act. Unless some other officer has been appointed Chief Executive Officer of the Corporation,
the President shall be the chief executive officer of the Corporation and shall, subject to the supervision, direction and control of the Board of Directors, have the general powers and duties of supervision, direction, management and control of the
business and officers of the Corporation as are customarily associated with the position of chief executive officer. The President shall perform other duties commonly incident to the office and shall also perform such other duties and have such
other powers, as the Board of Directors (or the Chief Executive Officer, if the Chief Executive Officer and President are not the same person and the Board of Directors has delegated the designation of the President&#146;s duties to the Chief
Executive Officer) shall designate from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B>Duties of Vice Presidents</B>. The Vice Presidents may assume and
perform the duties of the Chief Executive Officer or the President in the absence or disability of the Chief Executive Officer or President or whenever the office of Chief Executive Officer or President is vacant. The Vice Presidents shall perform
other duties commonly incident to their office and shall also perform such other duties and have such other powers as the Board of Directors, or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President, shall
designate from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Duties of Secretary and Assistant Secretary</B>. The Secretary shall attend
all meetings of the stockholders and of the Board of Directors and shall record, or cause to be recorded, all acts, votes and proceedings thereof in the minute books of the Corporation. The Secretary shall give, or cause to be given, notice in
conformity with these Bylaws of all meetings of the stockholders and of all meetings of the Board of Directors and any committee thereof requiring notice. The Secretary shall perform all other duties provided for in these Bylaws and other duties
commonly incident to the office and shall also perform such other duties and have such other powers, as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President shall designate from time
to time. The Chief Executive Officer, or if no Chief Executive Officer is then serving, the President may direct any Assistant Secretary or other officer to assume and perform the duties of the Secretary in the absence or disability of the
Secretary, and each Assistant Secretary shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive
Officer is then serving, the President shall designate from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> <B>Duties of Chief Financial Officer</B>. The Chief
Financial Officer shall keep or cause to be kept the books of account of the Corporation in a thorough and proper manner and shall render statements of the financial affairs of the Corporation in such form and as often as required by the Board of
Directors or, the Chief Executive Officer or the President. The Chief Financial Officer, subject to the order of the Board of Directors, shall have the custody of all funds and securities of the Corporation. The Chief Financial Officer shall perform
other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President shall
designate from time to time. The Chief Executive Officer, or if no Chief Executive Officer is then serving, the President may direct the Treasurer, any Assistant Treasurer, the Controller, any Assistant Controller or other officer to assume and
perform the duties of the Chief Executive Officer in the absence or disability of the Chief Executive Officer, and the Treasurer, each Assistant Treasurer, the Controller and each Assistant Controller shall perform other duties commonly incident to
the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President shall designate from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;29.</B> <B>Delegation Of Authority</B>. The Board of Directors may from time to time delegate the powers or
duties of any officer to any other officer or agent, notwithstanding any provision hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;30.</B>
<B>Resignations</B>. Any officer may resign at any time by giving notice in writing or by electronic transmission to the Board of Directors, the Chairperson of the Board of Directors, the Chief Executive Officer, the President or the Secretary. Any
such resignation shall be effective when received by the person or persons to whom such notice is given, unless a later time is specified therein, in which event the resignation shall become effective at such later time. Unless otherwise specified
in such notice, the acceptance of any such resignation shall not be necessary to make it effective. Any resignation shall be without prejudice to the rights, if any, of the Corporation under any contract with the resigning officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;31.</B> <B>Removal</B>. Any officer may be removed from office at any time, either with or without cause, by the
Board of Directors, or by any duly authorized committee thereof or any officer upon whom such power of removal may have been conferred by the Board of Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTION OF CORPORATE INSTRUMENTS AND VOTING OF SECURITIES OWNED BY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;32.</B> <B>Execution Of Corporate Instruments</B>. The Board of Directors may, in its discretion, determine the
method and designate the signatory officer or officers, or other person or persons, to execute, sign or endorse on behalf of the Corporation any corporate instrument or document, or to sign on behalf of the Corporation the corporate name without
limitation, or to enter into contracts on behalf of the Corporation, except where otherwise provided by applicable law or these Bylaws, and such execution or signature shall be binding upon the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> All checks and drafts drawn on banks or other depositaries on funds to the credit of the Corporation or in special accounts of the
Corporation shall be signed by such person or persons as the Board of Directors shall from time to time authorize so to do. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>
Unless otherwise specifically determined by the Board of Directors or otherwise required by applicable law, the execution, signing or endorsement of any corporate instrument or document by or on behalf of the Corporation may be effected manually, by
facsimile or (to the extent not prohibited by applicable law and subject to such policies and procedures as the Corporation may have in effect from time to time) by electronic signature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Unless authorized or ratified by the Board of Directors or within the agency power of an officer, no officer, agent or employee
shall have any power or authority to bind the Corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;33.</B> <B>Voting Of Securities Owned By The Corporation</B>. All stock and other securities of or interests in
other corporations or entities owned or held by the Corporation for itself, or for other parties in any capacity, shall be voted, and all proxies and consents with respect thereto shall be executed, by the person authorized so to do by resolution of
the Board of Directors, or, in the absence of such authorization, by the Chairperson of the Board of Directors, the Chief Executive Officer, the President, or any Vice President. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SHARES OF
STOCK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;34.</B> <B>Form And Execution Of Certificates</B>. The shares of the Corporation shall be
represented by certificates, or shall be uncertificated if so provided by resolution or resolutions of the Board of Directors. Certificates for the shares of stock of the Corporation, if any, shall be in such form<B> </B>as is consistent with the
Certificate of Incorporation and applicable law. Every holder of stock in the Corporation represented by certificates<B> </B>shall be entitled to have a certificate signed by or in the name of the Corporation by any two authorized officers of the
Corporation (including, without limitation, the Chairperson of the Board of Directors, the Chief Executive Officer or the President or any Vice President and by the Chief Financial Officer, Treasurer or Assistant Treasurer or the Secretary or
Assistant Secretary), certifying the number, and the class or series, of shares owned by such holder in the Corporation in certificated form. Any or all of the signatures on the certificate may be facsimiles. In case any officer, transfer agent, or
registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent, or registrar before such certificate is issued, it may be issued with the same effect as if he were such
officer, transfer agent, or registrar at the date of issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;35.</B> <B>Lost Certificates</B>. The Corporation may issue a
new certificate or certificates or uncertificated shares in place of any certificate or certificates theretofore issued by the Corporation alleged to have been lost, stolen, or destroyed, upon the making of an affidavit of that fact by the person
claiming the certificate of stock to be lost, stolen, or destroyed. The Corporation may require, as a condition precedent to the issuance of a new certificate or certificates, the owner of such lost, stolen, or destroyed certificate or certificates,
or the owner&#146;s legal representative, to give the Corporation a bond (or other adequate security) sufficient to indemnify the Corporation against any claim that may be made against the Corporation with respect to the certificate alleged to have
been lost, stolen, or destroyed or the issuance of such new certificate(s) or uncertificated shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;36.</B> <B>Transfers</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Transfers of record of shares of stock of the Corporation shall be made only upon its books by the holders thereof, in person or by
attorney duly authorized, and, in the case of stock represented by certificate, upon the surrender of a properly endorsed certificate or certificates for a like number of shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> The Corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes
or series of stock of the Corporation to restrict the transfer of shares of stock of the Corporation of any one or more classes or series owned by such stockholders in any manner not prohibited by the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;37.</B> <B>Fixing Record Dates</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> In order that the Corporation may determine the stockholders entitled to notice of any meeting of stockholders or any adjournment
thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall, subject to applicable law, not be
more than 60 nor less than 10 days before the date of such meeting. If the Board of Directors so fixes a record date for determining the stockholders entitled to notice of any meeting of stockholders, such date shall also be the record date for
determining the stockholders entitled to vote at such meeting, unless the Board of Directors determines, at the time it fixes the record date for determining the stockholders entitled to notice of such meeting, that a later date on or before the
date of the meeting shall be the record date for determining the stockholders entitled to vote at such meeting. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a
meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of
stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; <I>provided</I>, <I>however</I>, that the Board of Directors may fix a new record date for determining the
stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the record date for stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determining the stockholders
entitled to vote in accordance with the provisions of this Section&nbsp;37(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> In order that the Corporation may determine the
stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other
lawful action, the Board of Directors may fix, in advance, a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than 60 days prior to such
action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;38.</B> <B>Registered Stockholders</B>. The Corporation shall
be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends, and to vote as such owner, and shall not be bound to recognize any equitable or other claim to or interest in such share or
shares on the part of any other person whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;39.</B> <B>Additional Powers of the Board of Directors. </B>In addition to, and without limiting, the powers set
forth in these Bylaws, the Board of Directors shall have power and authority to make all such rules and regulations as it shall deem expedient concerning the issue, transfer, and registration of shares of stock of the Corporation, including the use
of uncertificated shares of stock, subject to the provisions of the DGCL, other applicable law, the Certificate of Incorporation and these Bylaws. The Board of Directors may appoint and remove transfer agents and registrars of transfers, and may
require all stock certificates to bear the signature of any such transfer agent and/or any such registrar of transfers. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER SECURITIES OF THE CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;40.</B> <B>Execution Of Other Securities</B>. All bonds, debentures and other corporate securities of the
Corporation, other than stock certificates (covered in Section&nbsp;34), may be signed by the Chairperson of the Board of Directors, the Chief Executive Officer, the President or any Vice President, or such other person as may be authorized by the
Board of Directors; <I>provided, however</I>, that where any such bond, debenture or other corporate security shall be authenticated by the manual signature, or where permissible facsimile signature, of a trustee under an indenture pursuant to which
such bond, debenture or other corporate security shall be issued, the signatures of the persons signing and attesting the corporate seal on such bond, debenture or other corporate security may be the imprinted facsimile of the signatures of such
persons. Interest coupons appertaining to any such bond, debenture or other corporate security, authenticated by a trustee as aforesaid, shall be signed by the Treasurer or an Assistant Treasurer of the Corporation or such other person as may be
authorized by the Board of Directors, or bear imprinted thereon the facsimile signature of such person. In case any officer who shall have signed or attested any bond, debenture or other corporate security, or whose facsimile signature shall appear
thereon or on any such interest coupon, shall have ceased to be such officer before the bond, debenture or other corporate security so signed or attested shall have been delivered, such bond, debenture or other corporate security nevertheless may be
adopted by the Corporation and issued and delivered as though the person who signed the same or whose facsimile signature shall have been used thereon had not ceased to be such officer of the Corporation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIVIDENDS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;41.</B> <B>Declaration Of Dividends</B>. Dividends upon the capital stock of the Corporation, subject
to the provisions of the Certificate of Incorporation and applicable law, if any, may be declared by the Board of Directors. Dividends may be paid in cash, in property, or in shares of capital stock or other securities of the Corporation, subject to
the provisions of the Certificate of Incorporation and applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;42.</B> <B>Dividend Reserve</B>. Before payment of any
dividend, there may be set aside out of any funds of the Corporation available for dividends such sum or sums as the Board of Directors from time to time, in its absolute discretion, determines proper as a reserve or reserves to meet contingencies,
or for equalizing dividends, or for repairing or maintaining any property of the Corporation, or for such other purpose or purposes as the Board of Directors shall determine to be conducive to the interests of the Corporation, and the Board of
Directors may modify or abolish any such reserve in the manner in which it was created. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FISCAL YEAR </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;43.</B> <B>Fiscal Year</B>. The fiscal year of the Corporation shall be fixed by resolution of the Board of
Directors and may be changed by the Board of Directors. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEMNIFICATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;44.</B> <B>Indemnification Of Directors, Executive Officers, Other Officers, Employees And Other Agents</B>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Directors and Executive Officers</B>. The Corporation shall indemnify to the fullest extent permitted by the DGCL as it
presently exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation to provide prior
to such amendment), any person who was or is made or is threatened to be made a party or is otherwise involved in a Proceeding, by reason of the fact that such person is or was a director or executive officer (for the purposes of this Article XI,
&#147;<B><I>executive officer</I></B>&#148; has the meaning defined in Rule <FONT STYLE="white-space:nowrap">3b-7</FONT> promulgated under the 1934 Act) of the Corporation, or while serving as a director or executive officer of the Corporation, is
or was serving at the request of the Corporation as a director, officer, employee or agent&nbsp;of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, whether the basis of such Proceeding is alleged
action in an official capacity as a director or executive officer or in any other capacity while serving as a director or executive officer, against all expense, liability and loss (including attorneys&#146; fees, judgments, fines, ERISA excise
taxes or penalties and amounts paid in settlement) reasonably incurred or suffered by such person in connection therewith; <I>provided</I>, <I>however</I>, that the Corporation will not be required to indemnify or advance expenses to any director or
executive officer in connection with any Proceeding (or part thereof) initiated by such person unless (i)&nbsp;the Proceeding (or part thereof) was authorized by the Board of Directors or (ii)&nbsp;the Proceeding (or part thereof) is initiated to
enforce rights to indemnification or advancement of expenses as provided under subsection (d)&nbsp;of this Article XI or is a compulsory counterclaim brought by such person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Other Officers, Employees and Other Agents</B>. The Corporation shall have power to indemnify and advance expenses to its other
officers, employees and other agents to the fullest extent permitted by the DGCL. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Expenses</B>. Except as set forth in Section&nbsp;44(a), the Corporation shall
advance to any current or former director or executive officer of the Corporation, or to any person, who while serving as a director or executive officer of the Corporation, is or was serving at the request of the Corporation as a director or
officer of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, prior to the final disposition of the Proceeding, promptly following request therefor, all expenses incurred by such person in defending
(or participating as a witness in) any Proceeding referred to in Section&nbsp;44(a), or in connection with a Proceeding (or part thereof) brought to establish or enforce a right to indemnification or advancement of expenses under subsection
(d)&nbsp;of this Section&nbsp;44; <I>provided</I>, <I>however</I>, that any advancement of expenses incurred by a current or former director or executive officer in such director&#146;s or executive officer&#146;s capacity as a director or executive
officer will be made only upon delivery to the Corporation of an undertaking, by or on behalf of such indemnitee, to repay all amounts so advanced if it is ultimately determined by final judicial decision from which there is no further right to
appeal that such indemnitee is not entitled to be indemnified or entitled to advancement for such expenses under this Section&nbsp;44 or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Enforcement</B>. Without the necessity of entering into an express contract, all rights to indemnification and advances to
current and former directors and executive officers under this Section&nbsp;44 will be deemed to be contractual rights and be effective to the same extent and as if provided for in a contract between the Corporation and such director or executive
officer. Any right to indemnification or advancement of expenses granted by this Section&nbsp;44 to a current or former director or executive officer will be enforceable by or on behalf of the person holding such right in any court of competent
jurisdiction if (i)&nbsp;the claim for indemnification or advancement of expenses is denied, in whole or in part, (ii)&nbsp;no disposition of a claim for indemnification is made within 90 days of request therefor, or (iii)&nbsp;no disposition of a
claim for an advance is made within 30 days of request therefor. The indemnitee in such enforcement action, if successful in whole or in part, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an
undertaking,<B> </B>will be entitled to be paid also the expense of prosecuting or defending the claim to the fullest extent permitted by the DGCL. In (i)&nbsp;any suit brought to enforce a right to indemnification hereunder (but not in a suit
brought to enforce a right to an advancement of expenses), it shall be a defense that the indemnitee has not met any applicable standard for indemnification set forth in the DGCL and (ii)&nbsp;any suit brought by the Corporation to recover an
advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that the indemnitee has not met any applicable standard for indemnification set forth in the DGCL.
Neither the failure of the Corporation (including its Board of Directors, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the indemnitee is proper in the
circumstances because such person has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Corporation (including its Board of Directors, independent legal counsel or its stockholders) that the indemnitee
has not met such applicable standard of conduct, will be a defense to the action or create a presumption that the indemnitee has not met the applicable standard of conduct. In any suit brought by a current or former director or executive officer to
enforce a right to indemnification or to an advancement of expenses hereunder, or brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the director or executive officer
is not entitled to be indemnified, or to such advancement of expenses, under this Section&nbsp;44 or otherwise is on the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</B>. The rights conferred on any person by this
Section&nbsp;44 shall not be exclusive of any other right which such person may have or hereafter acquire under any applicable law, provision of the Certificate of Incorporation, Bylaws, agreement, vote of stockholders or disinterested directors or
otherwise, both as to action in such person&#146;s official capacity and as to action in another capacity while holding office. The Corporation is specifically authorized to enter into individual contracts with any or all of its directors, officers,
employees or agents respecting indemnification and advances, to the fullest extent not prohibited by the DGCL. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Survival of Rights</B>. The rights conferred on any person by this
Section&nbsp;44 shall continue as to a person who has ceased to be a director or executive officer and shall inure to the benefit of the heirs, executors and administrators of such a person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> <B>Insurance</B>. To the fullest extent permitted by the DGCL, the Corporation may purchase insurance on behalf of any person
required or permitted to be indemnified pursuant to this Section&nbsp;44. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> <B>Amendments</B>. Any repeal or modification of
this Section&nbsp;44 shall only be prospective and shall not affect the rights under this Section&nbsp;44 in effect at the time of the alleged occurrence of any action or omission to act that is the cause of any proceeding against any current or
former director or executive officer of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> <B>Saving Clause</B>. If this Section&nbsp;44 or any portion hereof
shall be invalidated on any ground by any court of competent jurisdiction, then the Corporation shall nevertheless indemnify and advance expenses to each director and executive officer to the full extent not prohibited by any applicable portion of
this Section&nbsp;44 that shall not have been invalidated. If this Section&nbsp;44 shall be invalid due to the application of the indemnification and advancement provisions of another jurisdiction, then the Corporation shall indemnify and advance
expenses to each director and executive officer to the full extent under applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> <B>Certain Definitions</B>. For the
purposes of this Section&nbsp;44, the following definitions shall apply: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(1)</B> The term &#147;<B><I>Proceeding</I></B>&#148; shall
be broadly construed and shall include, without limitation, the investigation, preparation, prosecution, defense, settlement, arbitration and appeal of, and the giving of testimony in, any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(2)</B> The term &#147;<B><I>expenses</I></B>&#148; shall be broadly
construed and shall include, without limitation, court costs, attorneys&#146; fees, witness fees, fines, amounts paid in settlement or judgment and any other costs and expenses of any nature or kind incurred in connection with any proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(3)</B> The term the &#147;<B><I>Corporation</I></B>&#148; shall include, in addition to the resulting corporation, any constituent
corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that
any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint
venture, trust, employee benefit plan or other enterprise, shall stand in the same position under the provisions of this Section&nbsp;44 with respect to the resulting or surviving corporation as such person would have with respect to such
constituent corporation if its separate existence had continued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(4)</B> References to &#147;<B><I>fines</I></B>&#148; shall include
any excise taxes assessed on a person with respect to an employee benefit plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;45.</B> <B>Notices</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Notice To Stockholders</B>. Notice to stockholders of stockholder meetings shall be given as provided in Section&nbsp;7 herein.
Without limiting the manner by which notice may otherwise be given effectively to stockholders under any agreement or contract with such stockholder, and except as otherwise required by applicable law, notice to stockholders for purposes other than
stockholder meetings may be sent by U.S. mail or courier service, facsimile or by electronic mail or other means of electronic transmission in accordance with Section&nbsp;232 of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Notice To Directors</B>. Any notice required to be given to any director may be given by the method stated in
subsection&nbsp;(a) or as otherwise provided in these Bylaws, with notice other than one that is delivered personally to be sent to such address or electronic mail address as such director shall have filed in writing with the Secretary, or, in the
absence of such filing, to the last known address or electronic mail address of such director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Affidavit Of Mailing</B>. An
affidavit of notice, executed by a duly authorized and competent employee of the Corporation or its transfer agent appointed with respect to the class of stock affected, or other agent, specifying the name and address or the names and addresses of
the stockholder or stockholders, or director or directors, to whom any such notice or notices was or were given, and the time and method of giving the same, shall in the absence of fraud, be prima facie evidence of the facts therein contained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Methods of Notice</B>. It shall not be necessary that the same method of giving notice be employed in respect of all recipients
of notice, but one permissible method may be employed in respect of any one or more, and any other permissible method or methods may be employed in respect of any other or others. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B>Notice To Person With Whom Communication Is Unlawful</B>. Whenever notice is required to be given, under applicable law or any
provision of the Certificate of Incorporation or these Bylaws, to any person with whom communication is unlawful, the giving of such notice to such person shall not be required and there shall be no duty to apply to any governmental authority or
agency for a license or permit to give such notice to such person. Any action or meeting which shall be taken or held without notice to any such person with whom communication is unlawful shall have the same force and effect as if such notice had
been duly given. In the event that the action taken by the Corporation is such as to require the filing of a certificate under any provision of the DGCL, the certificate shall state, if such is the fact and if notice is required, that notice was
given to all persons entitled to receive notice except such persons with whom communication is unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Notice to
Stockholders Sharing an Address</B>. Except as otherwise prohibited under the DGCL, any notice given under the provisions of the DGCL, the Certificate of Incorporation or these Bylaws shall be effective if given by a single written notice to
stockholders who share an address if consented to by the stockholders at that address to whom such notice is given. Such consent shall have been deemed to have been given if such stockholder fails to object in writing to the Corporation within 60
days of having been given notice by the Corporation of its intention to send the single notice. Any consent shall be revocable by the stockholder by written notice to the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> <B>Waiver</B>. Whenever notice is required to be given under any provision of the
DGCL, the Certificate of Incorporation or these Bylaws, a written waiver, signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the time stated therein, shall be
deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting at the beginning of the meeting, to the transaction
of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders, directors or members of a committee of directors need be
specified in any written waiver of notice or any waiver by electronic transmission unless so required by the Certificate of Incorporation or these Bylaws. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XIII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;46.</B> <B>Amendments</B>. Subject to the limitations set forth in Section&nbsp;44(h) or the Certificate of
Incorporation, the Board of Directors is expressly empowered to adopt, amend or repeal these Bylaws of the Corporation. The stockholders shall also have power to adopt, amend or repeal these Bylaws of the Corporation; <I>provided</I>,
<I>however</I>, that, in addition to any vote of the holders of any class or series of stock of the Corporation required by applicable law or by the Certificate of Incorporation (including any certificate of designation relating to any series of
Preferred Stock (as defined in the Certificate of Incorporation)), such action by stockholders shall require the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">66-2/3%</FONT> of the voting power of all of the
then-outstanding shares of the capital stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XIV </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LOANS TO
OFFICERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;47.</B> <B>Loans To Officers</B>. Except as otherwise prohibited by applicable law, the
Corporation may lend money to, or guarantee any obligation of, or otherwise assist any officer or other employee of the Corporation or of its subsidiaries, including any officer or employee who is a Director of the Corporation or its subsidiaries,
whenever, in the judgment of the Board of Directors, such loan, guarantee or assistance may reasonably be expected to benefit the Corporation. The loan, guarantee or other assistance may be with or without interest and may be unsecured, or secured
in such manner as the Board of Directors shall approve, including, without limitation, a pledge of shares of stock of the Corporation. Nothing in these Bylaws shall be deemed to deny, limit or restrict the powers of guaranty or warranty of the
Corporation at common law or under any statute. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXCLUSIVE FORUM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;48.</B> <B>Forum</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware
and any appellate court therefrom shall be the sole and exclusive forum for: (i)&nbsp;any derivative claim or cause of action brought on behalf of the Corporation; (ii)&nbsp;any claim or cause of action that is based upon a violation of a duty owed
by any current or former director, officer, other employee or stockholder of the Corporation, to the Corporation or the Corporation&#146;s stockholders; (iii)&nbsp;any claim or cause of action against the Corporation or any current or former
director, officer or other employee of the Corporation, arising out of or pursuant to any provision of the DGCL, the Certificate of Incorporation or these Bylaws; (iv)&nbsp;any claim or cause of action seeking to interpret, apply, enforce or
determine the validity of the Certificate of Incorporation or these Bylaws (including any right, obligation, or remedy thereunder); (v) any claim or cause of action as to which the DGCL confers jurisdiction on the Court of Chancery of the State of
Delaware; and (vi)&nbsp;any claim or cause of action against the Corporation or any current or former director, officer or other employee of the Corporation, governed by the internal-affairs doctrine or otherwise related to the Corporation&#146;s
internal affairs, in all cases to the fullest extent permitted by applicable law and subject to the court having personal jurisdiction over the indispensable parties named as defendants; <I>provided</I>, <I>however</I>, that if the designation of
such court as the sole and exclusive forum for a claim or action referred to in foregoing clauses (i)&nbsp;through (vi) of this Section would violate applicable law, then the United States District Court for the District of Delaware shall be the
sole and exclusive forum for such claim or cause of action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Unless the Corporation consents in writing to the selection of an
alternative forum, to the fullest extent permitted by applicable law, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the 1933
Act, including all causes of action asserted against any defendant named in such complaint. This provision is intended to benefit and may be enforced by the Corporation, its officers and directors, the underwriters for any offering giving rise to
such complaint, and any other professional entity whose profession gives authority to a statement made by that person or entity and who has prepared or certified any part of the documents underlying the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Any person or entity holding, owning or otherwise acquiring any interest in any security of the Corporation shall be deemed to have
notice of and consented to the provisions of these Bylaws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>acad-20250415.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 4/16/2025 10:22:53 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:acad="http://www.acadia-pharm.com/20250415"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.acadia-pharm.com/20250415"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="acad-20250415_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="acad-20250415_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>acad-20250415_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 4/16/2025 10:22:53 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>acad-20250415_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 4/16/2025 10:22:53 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="acad-20250415.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 15, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ACADIA PHARMACEUTICALS INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001070494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 15,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-50768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1376651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12830 El Camino Real<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">558-2871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACAD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( /*!D%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( /*!D%JQF>51[P   "L"   1
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M6NU2)>0Q2Q07"9%L,[8\Y_;.[9L.^1V_<W90)\?$#&4MQ(MIS,.Q91LB%K%
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M6A4%![?U? X]V(*?1\$%?A[VAK]@*%5I<'!'?Q"F7BYV(D$-#A?I]88M=SA
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MP/6-$/J]8;X$E!]R)O\"4$L#!!0    ( /*!D%J?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M6@L5!K!O<B )+LF5&U)=Z7FFMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0
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ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( /*!D%I&QTU(E0   ,T    0
M          "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ \H&0
M6K&9Y5'O    *P(  !$              ( !PP   &1O8U!R;W!S+V-O<F4N
M>&UL4$L! A0#%     @ \H&06IE<G",0!@  G"<  !,              ( !
MX0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #R@9!:Y."\_HP$
M  #4$0  &               @($B"   >&PO=V]R:W-H965T<R]S:&5E=#$N
M>&UL4$L! A0#%     @ \H&06I^@&_"Q @  X@P   T              ( !
MY P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #R@9!:EXJ[',     3 @
M"P              @ ' #P  7W)E;',O+G)E;'-02P$"% ,4    " #R@9!:
M'#AEZC\!   \ @  #P              @ &I$   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ \H&06B0>FZ*M    ^ $  !H              ( !%1(
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ \H&06F60
M>9(9 0  SP,  !,              ( !^A(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      D "0 ^ @  1!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d905282d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>acad-20250415.xsd</File>
    <File>acad-20250415_lab.xml</File>
    <File>acad-20250415_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d905282d8k.htm">d905282d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d905282d8k.htm": {
   "nsprefix": "acad",
   "nsuri": "http://www.acadia-pharm.com/20250415",
   "dts": {
    "schema": {
     "local": [
      "acad-20250415.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "acad-20250415_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "acad-20250415_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d905282d8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-04-15_to_2025-04-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d905282d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-04-15_to_2025-04-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d905282d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.acadia-pharm.com//20250415/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-25-082809-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-082809-xbrl.zip
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M\_F29?<CI2VM)8M;0K;:"J\(<H&W0A")X"P#;*=PIKC!PHLHUZW>#><['M&
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MRQ-!F@FR5$C/^!JT87C(9^NE>.):'>G?+Y2=HNEOV5%G_@=02P,$%     @
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M ZWUZ.R+^N1?(]LB0^8+[CJ??JZ5JS\3YABNR9W[3S^?WG;/SW_^5V?G9!!
M,VCJB+;)^*?"( B\=J4RZOE663"C?.\.*_"@4J_6FP7=,!2E8.PQ$;?N4]$K
MN_Y])7J2:>ZXCA/:<>.'AX>R'!X[F(%?P1X5:%2"5LSG1M1O9''G>Z;;0T-V
MJAT='57DTZCI1,MX@GJUVJC@XQX5+&I.#6IFFN,/G):\ ?7MLN':N/Y6M5EK
MQ6L1?-I*8/1:Y<]O%[?&@-FTQ!T14,>(YPD#?^:JCBKP-&K(A=NLUP[F;$&W
MB#N,9K6M05L'-LS^_'QSD30/IK=/FE8"GSJB[_HV#0!E<*16J5HOU?=3@Y0
M)3(#12BR:)S#4J,6PQ(FY_.VFH,B/C5SJ*D;[U?40]UT-K(@FA<0W1DUX4_
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M.L!#Z0D.:52AP5@D9CK\:S+0>/,-#W3#8@0>6+SNO$MH/] !INGPA&EQ*1F
M9I=9?A]4,MPFD412-=*X +K+2-.IB">E:20:$L:H?#UJ&NFL20T%R&/3[XE0
M]QF<O(!'.KL.^^*S^'H$S!VSI'=#$V,R>VK.O>21FB<N/X+?1F-IL!E<3Z(:
M&Z#HRYVE'LGI,R/%F"BC.SSAXRF1IYGX6T=-8YMH>:UB7X2-/'D<> + $$)
M#LD@\5"R16(T.:15$11C>IYD>2KXMQ %33 %?=Y3[L),1"ZB6%0JA^P=8 %[
M"N8D\YNR%AYC.676520)TA)0X4'77OT3,H&'XU#)X^ D5^4VL7' I<UO<I,:
MXSTR=*6<Q%Q@'LB RIZ<GSE"820BJ6#^$ 6U'#;'+Z8YQV/7+;D'Y/$=V1H[
MNS(7PY.<B;T'WM)_I9ZD>6PK$:5X]D-8D(D^)L 3[B3?^BENE?:\@/XJ$!\G
MK%>9B2##)E(P]RFW8#K4P](<$;JI*$XL@?6R7HEAEOBI,HXE4D3P!>D 3IJF
MAVQ7@Q/!3J=S#E?7$DL:2X_="Z$;WFZA;%P];&3CSO#[H420+N+,Z:%*K[O+
M>*4>^3V8>JM<T+&B=1>S2X1IJ&T(2ZMX?HB1[2@/;;D2Q*/)DHP%N6-[)(GO
MIOAR' _?2>>5[)"=C]22=Q8P3(HE-AR5^8@8?D0,7W7$<"IF[A?I;DG6I6Y-
M_3LU32RWD0&^1"?#<!<Z_A;$^] /R!,/5-X7@KD?CAZ^/R8#T+<210.'A[5@
MT# WS.0H/+Z-";6;R >8N1%%^C%Q-L <Y0V<&/>-6PHS,,@ #-JJ6=IUI8=,
M9R=)#VGDD\VY*69X(8(I*!!G.ZTWWH0K&Q//@*T8H4";6;  !P##<\)CH5P5
MNV\<5PJ=@ZTZ*F0&@785ZBN(M!6/AY%X[&/&(1T6&H_4T1LZ(RPU0OZPZO5Z
M1/Z_,(?Y<-[=5-KF!?#WJ.8AT&_9B"[]QD(+F1?WY9?N1905]^8/_?!U^A%T
MTJUD\P,@?B1YR0 H6+JN']H3W"#&J[X/,V[N\JN5]IBV YJ@Z* %(Q41[N =
MQ^U2K=R2/ZX$#(FL^\>RI*%U+!.QZ\<(FE1R"86Y_U9).YH W#"0I12RI@++
MZU129V"IT,'0#1@LSGUZ2-5>$J2T']-S'U1@?TG(?3@N7CK;,%F?AE:09Q]X
MN]\0I$;&SYA-_7IWK"1+$1KC(W<==[3K=4_E4=LN9@BDKP!1%5VZO8J *P]4
MSE&(JGJ>CLB]DN+6&!/ I7,S[/V-J08V#?"NR'?!H298$O0Q\&)0@(ET5RM@
MQ%$7VN]S&: >8C8$1O+8??2MR$:1Y41[ E]%'4=V>K[['=![H2L07[$N%[%;
MGGJ;RIOD=IVC-Z0IZ6P#26;4_-L-?2>?Z*:)\KVPN(COZRH88T"1@F)?0NR'
M\%7@2/*F"65A<ZS1#(%4=9[U?Y*\0;V,Y^%Z+^),%$"G'TLN]B7D426L<,:A
M)>ST>?GGRX\Q7O6&/(HF.4QGXJ5K^; <0 =XJ:SEUF:]U*R<B-- QSB3O:\'
M>YCPUB$+HHY.C)]".53F*SAN*-/O\JI$H O+])2V#"S2[TB<T?!<1%YEZ*^5
MBP?6$_CBD%!D\PS3R\BXF"CR<N[I)>GDWOPVWX,QT*E5GR#/)1_=%LGMJL@W
M,0B)EP]0S44-Z57&L)^.7LNDRU0)I*1.U5A[?%3B*\=L!,Q.F43R-^\1PGMF
MMW:0WUR3ZYO,8QT$Q!_0D2*AQ)V[IZ[<P'P"+$$84F[1'K=2#@R+BWPFVZ0A
MKGS)J<H9&-7153EQGM$4QZ*> WV!'V'KC[#U1]CZ(VS]$;9>5H)L,ZC0I6$2
M2(I"?TD@:4@Q$(V*@%;IXNQ7$TO\9UV[D"2U2@N!IR_[>/,2O]YX]:Z-Y"80
M4Q\AR'D1%6-D<AE52G* >>WOQ+DAW=T(%NDKC &#%E2?6U$-E[2?N!,&RMJ1
MU"4KC.: \'VX7^? +TJI-]^%C5=O%<U7FGB>XA73JG1C8P2M/1U!EIZB&-6S
M1/!..,=DU#CEDTS@:#/\I**GSC@BDW?%(R8AE0***I^+$ F^.:KT17HN,9=-
MM:""Y9%.<>8'-QIMC^ K"=47=#=;EN1'NNXZ0=SL$;P+YM0XV.[]*I@6.:7(
M+M8O^WRD_1KR&@\I,/JR\#=5GYSW4*?=%4D.%!+1K/()ZIA[@#W28\*L\=[C
MYHQ<)"J*^"Z2(@N=9O/5WL1S-O*BFJ:\"6/CM:@@S,;IND\X8N1UMH->-YDI
M&XL\63<GWS_KQU53T<T8\N;6@."%M0\J+)4MWWTE15'RTH^IP)H*(E5L%B68
MLA$6*ZKJUSF0DS?9ZG))PZ+<%A@'"@'G";V''T60\QZ_?4[<;&ZW]OE6IX!H
MI+7PE'4U:CX?5)+Z'I[EJF0S#0UFH$#N1LO5:>F-H\-KS3'510HR+RE!H&#L
M*0M94[L,&$5W>BG2CS2ZKAOZ,D2!U@>@2JP;3B8?RR"'(W&#69:\945VQK 5
M0VL#Z^BD*'<MII=D6*% ET<?M;Y7PI*5^^Z/\FV9])DI$[1-O$J< SW+'4?5
MI-*KD]UBK'.!_N5:853KH<\!#DM$&2OYRL34??JY@L2,NW3*+;VIS:W]%J6-
MACW>RD711^5J[15?%/TUOII>TK*Z,AK)4E\X*Y[\!N@IH9:BN9NLY^->VR7B
M?:W%\;Z/<-]*.!A=P"Q?4W4I74;/$/![)<#Z(N_-D;=YOX!(WE0X-LJU+:IS
M)Y0,?/F.E:-JJWY8-]FH42L/ EM?S:]O1K^);D;_'-\I/^_*^I,*?>-&U]2C
MJE6;6RWR',H,N'L&0 Y DU/QMR\TH.0K!^E01"^E:>KXDE:)SV4DG/SY^>:"
MF*X1HN!,5]DE.MA'BDTZQ69;9LYR+R8]_^7R].Z/F[/;K;].X3KU*I]4EIB=
M#N4NO'(DF'Q%D4RH-JA,[)2O%_#5:P64L2%@MRH+%#T]/3:@5C_**)97G>@&
M:(R%#GH"LOG9;_JM 7E]*HO63:DR+:]AS7IK:G/)86:\<W5#BV@E:5U/+G&G
M[^]Q[_Q[96,NLA_G"/FT+;F6F$="G2'GY:.LH-]LLV=1&R*8@\1F[<R[@_;5
MNX-65!Z>!7&D*O)YW-[26E=TA2UXH]J*LK B*N0WYC@<$]=^*Y.;@6LR,2>"
M\,&DGH1)33N3C_-XOO,X&X%"*(V/_\4 ^K7/$-9.L$>Z \[ZY(+=4XM<J7"-
M-G3P0GE4)'T64'^\C/UQ4NFYYAB^@S5J=?X+4$L#!!0    ( /*!D%I--16Y
MR&L  ",H @ 0    9#DP-3(X,F1E>#,Q+FAT;>V]ZW+;UI8N^I]5? =4=O4N
MJ0I6+-M)5F*WJQ1;3K2W8^=8RLI:YQ](@B(2$N "0,GJIS_C.F^8 "G)-NU3
M[NKNR!()S,N88X[+-[[Q[->+WUX_?_;KZ<G+Y^/1LXNSB]>GST__]>#QT?&S
M;_E?\.MOY>_)LY_?OOQW\O,O+]Z^?OONO[_Y\]>SB]-ODO.+?[\^_>]OED69
M/UCDQ>6B_>E-5:^RY3?/D_$(OO\B+]N\?O[LY=D_]</7Q:Q=_/2/H^^*\ILD
M6Q:7)3P@G[??T&M^UX^MLOJR*!^TU?JGA^OV:2+_GE1M6ZWX5_.J;!\TQ?_D
M/QW;?\^S5;&\^>FB6.5-\B:_3MY5JPS>=/+Z[)<W__U-C8/\YOFSGY^?OE\4
MDZ)-8,+)LV]_?O[LV]]QQK$!/'KR 4<PI26A(9S\=OKFY>G+Y.3-R^3=Z?G%
MR07\8\M8CA]]G+'\_._7)W^>F[?'=^)CO?SMJWU-^^3%R<NSD^3W7T_>_7;R
MXO2/B[,7)Z_/D[,W+XZV#>E#BJ4SHH.3Y.4I[,7)N]/DQ=MWO[]]=W)Q]O;-
MH3N<;^$\P<]RNN#<T/\^6R=->[/,_87+5YU1XJ_6V67^8%+GV=\/)OF\JO.?
MLN5U=M/ R7WV[1I?\NN[Y/SL_X4Y/_Y&GTNG_Z?_]2/]SS?)GV<O+W[][V^.
M'S[\+S.3%Z=O+D[??;;G_YZG[R,-9:?#]Y'>O?WL?:SU_R*/WB>]'][!FKP^
M3<[VII9?G;TX/4>%<Z?7M_G[]D%1SN")/SWYK]L-!]]_GD_;HBKI[3@ ^L__
M+B?-^NGQ$?X3S)+G[_++HH$1Y[/D[7Q>3'/\PU%RL<B3VOZIHC_!?Y*3:38K
MLN3W10:&RC3?M,4T6S;)63D]2@[:13X>_>__=?SDAZ?XQK/G+ZIZ7=49#^.,
MQH!__L?3PZ0H$_AX<MYF+3WX9;[,KK,Z3[)R1G\ILQ7] 7]VGH/?__YIXXX.
M=''9)EF;-)OI(LEFLSIOFJ199,ME,H$'PL]Y"\M5MPM][32OVP+F)"\ORJE]
M0^2ER0$\!'_7X*!6V0T]=Y7#YLQPP-]6]7@$;\7)S))Y7:V2%G8D:2OZ;TK?
M]1;&?_^9^_Y@I? X?TZR\\C(SEN8%<R;Y::Q@N,N'.\"B$B5++(KWMU55I0M
M_!_\PTA6G:QKV(5BG2V3]3)C89ML&K"-82]U;_DOL!>R!?/B/:SWY(;6]^<J
MJV<D2D4-PZ_J)KJ3[C9TOQ(L?BH#OG&FP$-NQB,=587KP&-KT@2V89%<%^V"
M)CBC'ZM-VR?M3=_8\:4=24IF.<C\"E8%EPR_:=8H,E=\1)W_9P//9"G:EP;>
MEPK6:^AT/#H_/7F]913??_K#]-@<)MTW$)(\6]K#U",9V:Q:@\Y+IN9K#7SM
M*#G/BAG]*$=D/-HT?$2F&4K*90).&XA.ELRS:5/ F',4FSI'\:GP3!6K->I/
MU/KPL3D?,?BQSM=U-=M,^5\D\]=%DP^IIX\O5V?[\GS.+]Z^^+^_OGW]\O3=
M.5])R6^GIQ=G;WXYWS:D/8C9$R-FOY,&?3M/?LOS%L1!U+;^2[5(TU;3OQ?5
M<I;'M:CHWT6^G/G*.4V*.6C&\B9-\H+THJC"JA[6A*FCUHV2B]RE ]K^ -Y1
MM U\O0&_*,\/ATY0BJ8 ?KJIX C,BF9:YSBUU%&Q[2+CT:YX>>0V*ZO6G3Q,
M5N8^'DU@>CB)H@3;))N9C^%+EC<X]E6>E;2D=;ZJ8 FFU6JU*=$2P'6%-8!3
M=E6@7;$!46 =_TM>YC4<:7<'7F?7NC'=6^4@M#=>_O+B=6B!X>4D,B-6X6,8
M[[*Z'KPK]F%R?&?$]Z0L-[ 0OO#>=[0_WF&T!]DAC0D%+.-!J9#L=H12-$CI
ME^L-_+*A#<R7O CX\\Q(*VX4?M@Q-JQE!'8("AQ(S3JO0<1 GN",4$P"Q#NU
M9C#)(5ID^)092@P^5P\O'2WW!.(1BENSMSN!)W ZN@OD+0[<-U=%M6E@],UT
MD<\VRT&C3B\V6+1V78&22.$LV2_"$*99.<V7@T])Z7:#L>DRTZ5&EET=4W@P
M]^L%+D1\3#/8N4M8KD9\D UHNKIH0<N(@J"%HYL2XS3K'J^\(ZB)*YG_6+??
MR(GXM'&.8QWYU^#9'583'B[GD0PJ&!3>(.)/D[CHP5C  9SD>9E<%E<YR9Q[
M3HZ2-Q5<2R2/I%'@P#?X(^H&HSGPD,9E%(\[JHFJ08\=_A2H$C;_IO!$N'YJ
M<WC&(^^PBH)89;.<97O+Z?XI.2@.66A!T36;#%QU&6/$J[<+TZ<L#N3<-IOU
M>IFOT/,G^[6M#F798-CX&;ZY^7@[7GUW89[""'6([G?'HQV^S+8T:)X;/?3_
M RN'EWK1MKFQK9_BY^ USGMH$G9F,:4#&B>Y!IG(P@_"RZMZIG,DW0*_A>GC
MB@673["TQKQ J0$3R+, OCN8',*3QB-X1H.*'NR)AH(?T9A'LB7DT?A&R,_T
MN)@9@A,M=IYG&[US72E)]8D@'D6+%P$,ZPK-K<"@TY?#AJV713X;C]!(Y?B3
M62]P>39UWHDBP>/]Q9.QP:QYID?)BR4X7;F[\?21SC?!FK 7-;X\?S]=PKF\
MRL5>G).8N:L#$UIE?^,PK4[ V32;R0I=//]LBP**G5;_?-\[VG0G8VK"QM3)
M#OH$+NX2#074FV9Z9NU >X&+BA(),DL2Q881C+I%Q3O'0)V[C!F?;VMKHZ7,
M\;JA&)U&*<U><Z#(#LW=%C,Z5IJT2=M'S[^EB!/="<;"F]35YG+1ZIY&3@-&
MGJ9X<M .2E2BP6*RLNP8^O?8[./'=]GM@G?[555[R^1=8[  U@#FFZEO ;HB
M@]K5%1J8N7/U3&.'LGL>@\.<AGHU66V:%@T_.*7@V]:H[TO5&G+#P5/A9LKJ
M&]4[-LB9O\^GF[:P\<38!8 +06H/9YTU*-"!&NJH;YJ6&?QXQ*/G,"8.>+,V
MMK]_A<+3YH@^H!>#)&*$%B2Q$(\AF."M1S;MK.A1<HX/[K^J^ 28AX(E<2(;
MEI%,Y)D>-+AHF^!9).WH5]%'1<Y"_0^//)9':LHAQ71"ZCA8DD[ !8,?X.K$
M,Z6_50M.1I$F!X^<Y]G=KJ;3S5KV%*0<+IOJAA:^^X#'S@- 5!LR,9J\+G(>
M1+E93?AVA/6I66YH)?3#H.#XT_"':;8N6G@_+4S<Q"C07T'C]+JD3(^Y=$L,
M7Y0Y"&<!^T#!"W>H](%ET= <. :2SRY)5>(4RRF,LT8%U!BODP<,<WSBS)'$
M$;XQ(_?)#,GY0G*=XS&?4B![9A)$17D%Y@>M8@&F?MF.1[J:]-FF8#_[X#OG
M;?_9P'?@UV568,P)@YH@D2#L1JMGEW7.AT)"YV0(!]*<'Z9L,^2MC(@<WIE9
M)!&^F=U8_-#!]S(4QY4/CAWXGR6%FKREAC6H-DN*)YE1D59$([69+NE5J/;Q
MQ>_1L(35I$DTU1(VD-0B_@GE0@,/;K0A?%UF'6-.U)@/HVJ -4P.<C2VBWGT
MCP4=8MRB:GDE*W2]R&G"I/9;,QJ4O4E.-SV&"/DFE%'GLT/.<V3T2!-TQF2;
MK )ECL2D[?H5<G78-7(O C_X]<2$TT Q@[+#L9V^GRZR$H3Z9$IB?OSCXR<4
MJ%0[N!-HPT_@IZ-Y)/QPO5GFJDTN-TNY^V *J\WRDFQI<AG8(#D _;'<S%0>
M0*>1RZ=Z4G4R^FPYSXE7$A597!YP]$T%)QK?Q'^;9G+:61[GQ9(BP20$[EE'
M=S2OR<4(!$0"5[!;3UG,?U8]#;LIJ^J*^<#!P@OLJGM5C$=A8M');;'V"0X<
M#G>^@;/4+)*>TX8F8BL/RF!9L\G2/A.^[@:"\;04E\4$%J>],0<F]E)<(SY"
M<#I@%]<YV4I.H"ERS]?VFZ2&;JP+"5JM3IZ]>OOFPH0Q%G R'C3K;)K_5%;7
M=;;^YCF8_0_,5YY]BQ]_WN^U4O!;XO/3#):9Q0W?FX%- #;O9"G&#KHB? 90
MU^/FRPJA-*'9:S^_Q) TJY;?Z?SF[#O.X XAW8@VIP3E[2TF2Q=Z?[ MXY&Y
MMGW;,.HF<#0?;C%X#Q@.<PY&2KH_X_BJ_PK'7[96C7R9/FRO/[H=:[8!=QEZ
M<KN1VY?R,0]??.AD'F _\GP6C"2TE>4\6E"$]\JCY"0RX-9&?27",H$-;S=\
M/6=+. ST-S/K3;FDN%%@%XLZ;M0\#()=/8^5S<[S@^8P[L!TO.:TL[WAVE*4
MU_O2]]TO)<TZIZ76#3DP+IH,7:QAV.>H/@O-"#@5GIG!ZMY"3DCCXZ0(,P(O
M)\T]M#B)LS9T&>*EZ6I15UGR>CE/-AN&LJB2HKB2+S <_>AK./K#^^2.4VXA
M)71!@,"5=W+408_=UE-/OGQ''69]%T\]^=(==70[!SUU"<&%CGKB^NF3FJ3"
M1K:ZCGJ&'\KG>%E-ZV+MAN>-X.)%9ERD6,#,W ^>OX['2)^EF9+$/1"./>Y\
MGO .J'"KY<:8\VP7XE'1C(IU,>4&0@>J97WN!P3Y+;F&+VD8,!5R.B*RO@3S
M;)-=YO[0\?;'+Z#8'%)<@?T/,G4;'1G&&XV[Z>+MO%4BHUZ==IPL[&5>PYTY
M'J'KC6D C0+\CB\O<6)=T\_(:&Q!R?@L09[@U+6YQAYLA,3-4WDO2B5B4#1F
M6)W/H"4.UMYL0Y$,-K?)3M4/-+HIV27X_Y<4D[#:3^ ;Y/; 9#=+CC60P4D&
M;U&SH=8LBO4 :-4+QX3.TOV]I'LC(>YZ=\CE<4''C94-BV:@C+9,B9Q]48U=
MS4A:D0(@T[RXLLE]H[L)D7D'Y8VF[Q(EAS>; V^"R+!W(?_AQX<MHB?0JH5+
M,*N7Q4Y?.WZDWX.Q6?&;%W6#+D&)5U.#UX]:ERMPX-%)7^(W8,)T1&[@A2I*
M?)&.1W)&GR;/SIYK("1-%M4U:)<:HQ I:9@43<N_Q"!DI0%O1I.5XID]:2FY
MI-*(QK*ANVA"#N^9V16:[W"=L=:%-7K\$->@L8N !FF^S&YX-^T'?Y /<KI<
MGN\L$F4H!U?&<P$*]-7"(6)FE4 Q!S2*?,47ALVXX!\/&:<C\BL2%^3A')D/
M+[<P4B//45%NJGYI9F<OD+#QZ#8B%G'].(1\"X'GS\$?S)7N'8/!=V'.V]5N
MQ_JM>;6$^T"O4?R-B?NN-Y-E,<4G51N0'@F2\WZKO'F@"9 T/D:874.,1(O^
M3]/"1/4%>.U?5B0,!>Z!R+%@T^%.GOU5;>J2WP4&B0"+Z-\'!J75'9<D]P^C
MOB?)#<])=MV'=Y!@VL]D.\W<S5V;QU%:4<3'0YAA0(C3%4D)*IORYV"9%Q7+
M/"A^-"@,/(G_=&CBPQ(?">,F@?%'MSR:8A.T.";5U3#6_&/>0U<6D_<A+QZG
MAL&8N!0%E@UQ-@>C&+PJ)25Q1=D.1YTT--P--U%T_2;ETX$'5 )%_&7UR"0&
MSG8B64&29B:3:HX!71PAXQS*MJZ6C0;_9 ;F@/@ C#HR)';VV(A"HXK_-1X=
MH(T/J^)%PXUYY8?#.1X".@!WXLH8"]%OAG@1\BT2S=;Q-&TRCAP-QP0UYB6O
MI8E5IO$G<&QEO0:UJ_HO8L5-JNIO<M0P?H-1J@9,.5!TB4G9I;=*V"4V7\>!
MJ2TY.XT ]6U&VLGE>3L)'S\04#:KDZR48_YNLP0)WAIK/GX\>_!88\P6.:&I
MCT,\9.%&.-:)-4I(TPC\M1FR0:X.Y6JU3^1#B8%"^ _I\X:!JWJ/>Q/&L# E
MD\T.4(S=WP"RZ;>N/I]J)TEIQR30-/$,S,ECD)BF71I2W.!'8"T].2J<V.R<
M-?(E-&GF&H2,4#-J6_9QOFDW=8Z2^.(0LS.^>TRJ0#.;<$SK&F/Z<N.-1[2+
MYLX\L*DZ=H#A%:A0X6^'G>AB '?QE-&!X,1P?%>5@?-XF_"E1B$??XU"W@\4
M&U%_VPY?ZCKEZ(I?59QZXDPFXS^+DL03<Z)TO#0%RBEES1[.Z(_'#W$ Y'<(
MFA:T5]Y>HUF%QVQ5263"'G*]6-$T&SKFJ8(DZ<,T; 7L^F&DHJ:+B-(>^FLM
ME5D6*QERZA_AQCO#]&KO##<!3J G!7[6YJOD._PV_?2])KDIX7TNF/KD^/%+
MO#[UW^,1_H)!&<Z-BF&3>K:4FUA5",><3,:0TK)8=)8%CV^<9X$.>VFB?0%$
MPSB?3N@&LR%.I47LTA.5FFK!)65_&-2:^CJIH^\M^)0N"+'?V'9+#6)A"])4
M 0 :ZW.N1H)V_@<\AV)>Y#-OOE<&0'S(&)<9A[_80@FPK"[,B3P6DC;2QR)W
ME.BBE\B=(0;H0:C3,_T+R=1X%#>9?3/Y4,)J$GWT [**X+CC"*)QB>X(0&Y.
M#Y..R*@H^N?8/YE9S9%'/VZ)X4T^&80.L1+[Y"1J^) PY.4E!F,)?>$IG=O<
MG" M9+(VE6.JJN'HCE9#JMZ;U*, _;4I34A[6G&8UOLH[8QQ);E@&8/Y&#>O
MZG+ R%0K;]MH6/0[NZ)VE%437C"67%/<(U3-\ 9V0R_K:K/6>*\<B(/W&F*H
M-,M#OC7!H[.KK%BR?NIBHT1!8\B5ZBGPS^!O5ZXR@=59YA@KDR.%U[\3:X^X
M!V+HB$9QU3"<6["!.;5+];MAHH&R:M:[(SS@C9V=P3_I^AH0%7P7E4[#0'RO
M8(*V9 V#M*%T]Y56_C"-0>MQ\#_VE>&+_*=%@3>1Y#TZ%MLQ+,=/L@?'/ZIC
MX4*BNF<-COHK<T6$MBX<PI=@4URQ!KV :[)AG'<,CP)R/!X%[LIL4ZN/KL5I
M"1@%2WC:P?&CPP=@%L"L.%Z2)GY2R W5M.ZK]5 .>H@6>V:P<T5IT6,FP0%7
M'*[W5':>7I[7*Q395- ;,*/X*L#:_:)K!V:8BTN02YQ,$#F9P=*@JM!J"=Y<
M"HY8%- \QUS7,N5SY@#+L$)NZ:&'4%1@'J6DDNEI_NUH8KH6T.G?UH'%*(7I
M[CK&KG1A[.A[%]M3L+Q-PSO7*4WIFA:1]TA^YU<G;]8%H=4Y8@#Y^@Z6NM>"
MBP(]S=P5P!=\G4S> DYY9\4=7=VH'A2<*(,=@[")>TF)_N3L0+1ZM0<^ZEJA
MDA,-M48//M/8ISM#*BF&*IC*_12X3*7 )0*44KUQAXCE@5]6%(8LP:V/8@A<
M:)/U[,G< ,$ <RVK,95165O;%=@#QP5CX][#/FU/6Z*-UK$=#8:7JLH\P35_
M4N-"APXZN=[D$DRL4=XD'H0ET:(GQ=QJ)%QK:A%YY.0GS!2F1]I;,)^&"<B[
M2UTCW\+:7".<3GQ1A/AVM7_GJ(I_5JOX)::X(C>2ER.,A?[9.G1S<GP9PQ4^
MD,H05R*-C2+(X_!3!%ZM==9)+-?H1/-*^;9('56L6Z&C>!UH92F#G:NE Z=^
M4V?3&\%KZC\/U;X(Y4NS'3X&@#$86R)O7/1M#!4-3('G-4-4+P] _VD&T&.A
M<P 3K$L6![H3;WJQBF0\X^$HN;96WN-""O1]=@UXQXKR*#GK !WMT<9[S"QS
M%#\U7'LXU>!J7%ML3;O?$3(5)"$C,FF3OR8)&1S;\>A#G=N!+)]:S<Y[AS<D
MV;8?]]L0T>T??TO:ZZI/2QC%I.OOACFBJFDPR6HTT\ K&1D]K)GX",_Y>>0Z
MSO/K_NEHI*]_-BI=C@Z.0S-VFIT:+-Z[AF>4XJ:,1T&V/I)Y'WS*%PSV??(U
MS/ZAC=$9&Z-G44S/]IJ"@@"*B".TQ7A(-M-@\CNJ0;O8!(QGT;&Q@'H/I6Y=
MB5IBAC>&V@!F:D'X.HX8WX6)W, 1G_%Y-P!0@C_A,>J6;BA2.'.N"L<&Z#HJ
MT?AH)#Z9#N(H^NWF*$:88V#BB3>FR+OC7^\2NO72*A+L#BM]R'7<=9X.8L*G
M%%&<%/)D4;'\8*T"65\@NZ#/"C;^<+M;I\Q2!8"<EZ*UI?0?^&HD7,?.F*E=
M<$X#UH8KV29.OLNQM#BHR)';$T]6[D)#N89NF<O0K2D>GOFML<(Z?Z"?UX"A
M7Y08VT,OYN">:8XO[EIO4$<M.;_,B(RX()[CU2$<Q$D:7"06,6,ILFK.4$G\
M[@UKI&YZI$D<R.9W!U0\.Q[Q6+PXSN&'JGO(3-C"JWCJ'&M*!F73OS%^CP:B
MI+NF6B\EX3L#>^"(D!9/.M5CG6CS@<(?,(AO0@48T_7G)XB78P&6VI-IIX#J
M+F_$7L/U[E2GF.3BH>0T[%<'ZLC[AICL.,+;C$\A28=.KE$2@<8/E.)LS?4(
MGR$1QV64:[G!+;,E'$/0D>26R!$V@C&(C&_EA+TM=]6'@LN^(>X & B'LVTR
MDWRY&TD?+:IKKS(Z=8J1MRH$2=YFTU;S)UI\6\#[*3Z@4IT<^,"V?W+(_849
M=<AJ9-)JO+AH@;CA6QR)?V)<K"P.H?,&?N24:  (%D"'F\HOYKD>.6>_33A;
M:I9-C.+6:Q1_[KR8;:8%"NYL0X%VJ2'VZH%=;JW=Q.X# Y6BLA-8.QX?1IB'
M-A2!;OJ35C(O&U/^6:PF<+>80X&J:U7:K$HLSX&E],Q\G9E*NLY6C$=!F;B]
M,K=(&.V8)V)/^683<DW>$\,J02-$6Q)/W2TEQ.RH$P-+P[20)2J^K*ZPJI7>
M ZLRAT^0V:.51"FE*.;(M-(6&<DN14 B5T1;9R0':RTWQU]>;@J\*,OXC67*
M9]GX6MXXRV; V(1M&=;47LQ^9QJ16+@G/QR/#MKJDB0Y@H25N04:1I)+Q96>
MKMOLF(,E8=(!<@1AN=$[RN&6VL#/2S8\L<;-Q)U;%_@XQ5-(L0P6HSD8:#O
M1QW3[4AMMWWD9.::DQ']X)'[&DLU;IF"*W1WVS1U*^?EY:0<&;PSVZ6N/6(]
M=HU2H1Q,=BF;[4O"2<)/>,.<(L^H<YG&8IG!KV;=7^6'$DCHGHYY:+NFHN>]
M!0IK^*,+U+'0HVL0.M&2/*SF1\G;W9CG6JEEO ,K<(SXK;]\=>LD::-Q4E]J
M].^[K]&_^X%LMY[H+47JD0.]^U$]2OY@16>!2^YEZ)N*L2)#2FFZY1S*)*L4
M(TK2Z3CVM\$:$?'D+G"CCEU8<0<.1@X'/FD39(&1U -=MQ)!= ?O#REKV'23
MAJ'>D8J,#PN<HA2)&8 0 \AZ6AXDW 6ANFLVZ/X7@MU%D[>9=^.Y,60K&J>K
MO.V&)?V)#=ZELD_9X<'C7;>J1^3)D-&"5X9/*+3.+ ?C'.*3@U]B+CA95N"/
M4+L79FCN N1B;[_?_/N+;? <25C(#V9\6'X+K1>ZKBQC0E^R%KD.Z]J+VC"#
M%-FV4L;J)M4%U1J/[Y@+%LQT!J<A[9K#T,,?@[]:"+6 (,5)O$]L\3#5I2\[
M=:69A]24M CR-LP(T^%&V_"?AN!(]5P$.MHA:XOP82O,BS^K0!<;,/?2&4Y:
MM(\T6PJ"NY/K8$NEL"*?FBAUAT&PJPJ)Q\L:,V%<WFO-)!7 2@P( ^,7QV3@
M\"@Y"QDG/OFUT%.5IC'>MN(HI.=[H0H)8 ^&H7(@V^Y<EL;&W:ZN9_FJ*INV
MMABDG=7R?94R3UU72EC?O%/OQ&:XNI5 [MO.4?*9'J. &X210S[E>HA:VH/=
M$E>R0H/>>#LD\3I-)U7;.?7'(Y\7OQPFQ?<];JG</ AK0B,HIFA.QMB8ASZ+
M XW_3JT'MFE-A5E;S;ZB#-^2J/*-.\]A^OBF[YAR<D$U_;QU5<B4'F)L9?)4
M]]_BT:/]F,5J;- ]/D+^TQS;C/58\.-1:,(+ [U+- *KAZ'.AI2?%1U&;5(U
M>BA&+D\ES7B1%;4&<7W8EN,KDU5375.=SPQCTC<^AZ>I G)E/*0R<^-FO/G&
MTS>'1GAW!]SRZXQABJD%#&)4)U9ZMMT_8URSHZ;#9I8V?.&6N\<J"&V$]\YE
M&42K/:!P5%9CM2$FB&V)KI0FN#.T )X0% @ELRJ7;$*_P=\+3(YW;TA97.!$
MUKF;/!.\)]&P.M/P=)>\2-*TD?X"D;83GXMA6]7.;(.X%D\/;G(I'D$ICMJ*
M V5%5/;GBFQXJ7^$2_RN-FU0D4=[[J\+GEM[MQB::H:MLVF[A8.&S8%&BRVB
MDKBY5=BD$UG<5E/:C44>.B>*BDL-E]:6WEVQ#$NEY\'7M8XN-.N9=HH@/_BQ
MN%U&PMA5YHV=,?M'?[>CL649/OP9,<1@'^F04+9\A\,0!2*]JK;2?J3==E1;
M!=KK[$+UGFPS*(*]VZ=)&KZE,),RN\0?OM1 ^?=? ^7W"Y2W-4@)%X4@%D$J
M^CIDI55MQ<G*$5GX CR0@)H#4@R^K]5P=5464]8?4FFH@8.>[Q)73&M;07IV
M1D.6V?N;T-3H. 5&L>EX55UVQR/U,C6,BJX;;0'L^GZ[/,7H]+!3@PU+QHD7
M&+\[5*Y$Q[YGKOLI];NT1,JNCK,0/=J![[N@V3V1IO%P7<1!!)8:\'?QAB)S
ME*(GL*Y+RE)QDT!D"+T*$@-7FKT&7E;7R?^I2AX&ZGP"P:3CT8GM2O%[38:!
MV? _J5/++\MJDN.7K@4MA1Y#5I-<\LT*5DJ)#W60-32B637=2"V.(#[FQ3)Z
M,UG?P>D!@KME^H 0'(O/:G\GD<=I@M6J=7+,&,R@;)6!>QPXX)N9>[PY32BD
M?^HLR$G(QE2FOODF<:K\+Z5+L*HMCZ%^BV>(%2/2BZ#'U.!N.W2S:X7M=3YI
MX+Y_NC?:V:[HVLJ_"..<]T%3%!@5;1-1$':TP#PCQ_G)P^_<2*<C,K9;S..M
MW6(>1[K%/-U37[;8BKIZUQ\FZMV,> UN&-IN477G6;L!=_PF3<YAA3(.'OKX
M]TE6_LW,/1:SAN/Y=U7_G;R@UKGZSWTMQU5W-6BL%-]5TST0'UZ2[W]Z^#!9
M'ZV.DF4UQ5I1ZJY\9V9YQ,=F2Y"A#-MDW:1A*Z56B@NHX:&[84\-^./3'\_(
MZL7I**(KV \#31-+.1["C\F>)%E"[P&)$.%P.OU5+%>!91=/>WB!MI42ZQ[$
MV*9^\MERK[+EAIP40U0^PY5@H;]>8 -ZOJR(Z(9[J;I?BW 5NBP84=*+3N;I
MJ<O%F[5.<,&DS7K KA7QO6Q*01%?9@779>'KF=[AAG^ILZ(99)+UU;BUF<T@
M-P?1%]J5R[E.G$;32GF,641L@0K/(;)V.)>-NG'C45TT?]L=D27EX=!5*6-!
MG[B8=JL5*+ _/$J$#[QTE]-VO<'0HW([DIM\\ E(ZQ@++C5#5"HB/]/2,Y:<
MH^,H\7[6,MU9YONHH&Z]@,K9?_LCCC$'R0\:4V8\"GGRJK6\A9X*#YSED];4
MD5&<!)L\5ABKGE9@VM0MH3W5KH(ENL[66I>"O$V8:C$5B?"V)>ABVF9T;Y .
MR3X<M@Z%SN"9DP4V1DRM5% K @3@IKHUSCK EI+=!I;W [*U\$"Q8^J"X3&W
M/*GJNJ*>6W@YJ#XX"&X')Q^SSF[X)6#-M$MY(5Q#];1HQ*C&M6BTSE%YA +E
M(^WL3(2_)O.[S1.W&420&1<M,$S,0W3LDB4UYFS-EBK2N(AGCOAO([3RQP1]
M5*YT(,^ :)/G<9[68D"4,_-B$P:H6:^0].58AG?_4KHG=[A1SQ52_/-SP? _
M4QC_]T=TU^*')"?X&[O$#?Y^3Y5_&1L YWZ6TNS[MC"R=!P'PV>)L57-RXM/
MG;CN]5UZ/;^$HW6-%QC%T$'F/&J8%]V48RP[Z3.]O%A@7YI38]6]U>ABY?5^
MCS_,3]8ZW628*DZ#3*OLKZJ6%H3XH+9"]BM3'3H>.5$I6RD:J@1*8\/!+QK&
M*E]E4] W E]3QC,_5&H>!F>O\3JR&RWAC+EHG)R8!'LB<Z9-G;&R/CQ*3O!)
MPTEM=W2-T#':<K_(*T2,#"4"HF;L%U'EH:9=.@&!V$:+\+G)88D=,XFA6&R1
M]R^(WF>9<\*4N1IX5?&6<7F<)9&,KR(L7= WKT/[SX8#W@.1H-<7&,+^X6L(
M^T.KX(EMB! 132)+:1N--N6'!K[F]CV5,SY#Q*NDEK+N.3U*_EA3 #N@X>D^
MP>EJX&$YTNT18>&0(LB,Q;=.<G,4NA=+'M#R#B$NG*RL%]#[P<1JM9TZI7@7
M>!J]_FN4Q\*@Y&6=K1<)++\ P)TBD08YRZA&BPP7FOB\>*]L,TR,91J,X<I=
M(V@VZU6(?$'2[1 %975U(5I9>[()A =O]T*:K??![0IF])(EEM==@6"XV[;[
M(?Q>^92]3'/_+2?+SFTY=IJ3EMG9&SRK5=:URL_8*W?#YG5RH5UX7N4R#(I5
M'E3#=P+HBXI-L6C5O&<V5 &5MDT.S;7 RSM-@E&\Q>,Y)1P6ALDS0L40@^AP
MQQ27824@6B":!6U0P<5NII@-ZV%V[W4\T#"X*RX[M3KV;=_]]#J.#=WO==QY
M[WU;'7=V_"@D.O(E%M5GL\.9U,"A\3]P_!,\,5QWX39JC'[1Q<J[U4,S:V4:
M2SHNWAV1E3+O\2C.O.KM31;A@S_H(A*EWYFKU1@%(]$-[$"<17C<=]&C=/,'
M]2D8B!#0CES$6UH@FJ/'U(=]O1 _&A-0M"W;8.._9^=_F$O67I@_? ?W)\6=
M0 (?D)GX$]R]WSQO%\^^A6\\CY"\B8S:A/?=F[FYSNB/'W"(;NLWS^/=E1/)
M76KE,_H[I_J9 ;HDEZ O/,F[W*:LJ-UCYU!8#;#HNL*:.1#3:->"6&?=LQWZ
MT>'4[]22KK,4'Z8E76?%/U9'.F)U^8 MZ3XU%&2V+X8!56WA_@_S#FA3N"%N
M 4LML!,'UM82@@Z:50AMOYP2 @7[WQ?*3Q$LCXI@$$:_&W3^4Y0$Q*H M.MJ
M.X3:'X]N"]O?";'_)8#T=SW=%J;_I4;U_O$UJG<_8.I.H/+/N<:"2"CZBRP^
M14G%]WLHJ1B/#DQGKD50:>NY3QT6C<-.-4;??7[W:HR/5'CANJ(?I](^(N^A
ML'^<PN!M\D[%0CL4%=VY:F(?%FQNJ**SV:QPXYP=JI(0X)R&D2*$S;N$)P%!
M7%B*[MH3EIAI6ZL7=H#8(HF1D')N.,YZXPY=O!!D!MFPL^@.G:,N_I$VQX?K
MF+.^[SHO@QW_/J#,B?36@%\LP"@%1]SVVDAU/O/-<HF "ZGI194!WUX4DZ+M
MLZ^QI08R1I93%E7/7I3'NF!E;]UQUEL7'NTQ-DY;!KY*_;$UQYC LJ,7G<&:
M3H)R]K[UB@HU^.>4!T7PV!@KRH2CFC:6/!)-W813#W<0!\WP,Z(A(O0.2:;;
M'2Z.S%O3"N.H&$#DMF;$@7"?MUD\]]\MU'8:X! NTJZ2N?B,ZC?=O$BKG973
M4(5\1K"5'PQLY0WKX;?S +@2\QX].H5 NKM+,!YY:R "[91=V"N 6&CZKE8C
M'9QK)"&6SI;$V5MJ/)=^\?W##N-\+&"B/;]</1E+3'BA-=MX/FQ@I)ZJV!P^
M,*"G"8K[Z*/DW.FOQ#,6]GTSA?16Z=RA$0[F:3OM4XMN%Q8"TA9STF46-JL,
MR+=\:;0MC--XCU#)%(M?X? PD+4I+8&U+@+(I$#.O(0>KA;:$_H+20FZW<J-
MF880'(Y4* ..PD3<O?([K6 $GV[AP$*4\$<,-.7/E-2BW74[-J%H;CPMY)FL
MCQX_TH>]_.7%Z\].R_S#:)G_9U/5FQ4MZS]Q6=^)"\"ZYJ1-N*K)XM3\RKF<
ME=$U@:?BC@2H%+(#U7X;T,9I8C[G:"..&*$@3!FKH+S6DYNHZ+'D^>28DQL6
M-G,DW0NK@R +P,'TNVK3&AO7]EKDNZSGI-JDA* T$.I0M!M*/?V'%UZCN$Y;
M3#=+T0G"-]9U:35C+7 'Q:IZK7),I-^\T>+04CIS&"XLR@WSHLDH;):$66^=
MZ'NLI)M#5;,ZNZ9:*_!X2H0;^..&QR]SM/'M':%C,J2(F:.\\/( !;6"(7-F
MK_&N.9 -V5CGPI/MT-(T,M$<H1H4ONXU6&@2AI*!I&GZAV=;4.&+G#$IB;HU
MM5/IR6<L[X!\.YJZY'. .'1*KESI@WOD-T<4#**.A?9:WZS@:OL<QON6B,;C
M?QW ^DGSUFS2H+E5:*_625W]G>\4L"NK\@$-P[ '&"U*\["$:3Y2;UMLO,>D
MV;:5UJXTP] D.6%(U^"6,*^VMX0Z1#[O]C:RW/JWT$$F/,(OC98FDR4<R6GW
MBL51\B<W]@)3&X$AK<@%S<J8X?1#[EKDA8TB&RV>->%2,U?$%QIF_?%KF/5^
M8=8[*<T/>;EZ=18=&4Z[YJ%S'I$Q_PX',AVXJ]V#V5(G=:=Y@1=4@5-MU7[6
MBO:]WS6W\U8H(M/PS6V['V]_SR6[77-]-U:_C&!(V>CB#K];KQ94%,%X]&FN
MOGM??%M$^[-S&'XT#L.) \0X@76Q88H3TV_1#UA@"4,O]8;)'S.G$M6GL+^6
MJD=H^SBR/XN^MO T:WI>CL= 2MN>(<\HE=_=UJS:AQUE&D/\Z8.?$?QI5HB"
M96).$N2S#D,2-OL=PFI0I5$L.YO-:E93;3Y=H 9=^I%;<C+$WV#?P0X''8?+
MJ$UTJ &%,J>\?4O6,CO3LL)V(F9VPWAYP?;L%I.X9T@B'HS S\1C4G5N4$*S
MP,XC*C$+\')W 8MX:2,J#AH;?,FL:&#R-VBOS3:U!X>WQ3O=;JU28X@TL@X9
M39FWU\@JL!'VQKRT]T-G.1+'A<,*P *A@=8NU0E/;H:7GPZW0P$?<#9&$D^F
M#GBPH\,/%*>(BD_:R?WA=ADOUR.SY.VP62C+8J:;!\H 5*X'HYW']F_NQ3T?
M/QR/,/"9>MTSX](>1%1CL= ![*LO8TP&;2C(W3$RTJPO)KB]7[0:*O/BO2-S
MW=7OK4#C><+7E0#TGO')H-^OFV0FR:^88DH@J@Q=;-@TLW.XY?RS7IECO!9-
M$?=QZZ[??IM[YAL/@S>5,\EM:_;961['#XWI(?W?WE'6B6V+5UT(NA_QQU]N
MW<?,6B@4,>Z8"523Z=R4VKTZOV4NAHB0%6I>N!S?C?H]Y <9M4WV.F]F'Q5*
M9[M-@".8Z3-<15@U?\(4KPMB,+OD7_JKKU#%FB(:8XYTH?9#W&WJCF$,7B$*
M.B\<P4PTV^/D!DYUPY8A%>Z):T1=<;FTV>([Z3F&E8*P&9EI7D&PVB-M,IBU
MO5%O8[_@8-"2$/C^!,97M5*RZ\PE7E:O* ?!ZA \B&8AQ"7>BB). )&ERH$Q
M18TZK98&F4$W#=F/2B/A@/VIGYG1T^,1V:4-:B9\9F^)[[WA%1]:$QP;3?!_
MJ@*.X5MJ?(>NQSFN%FN$LPX)##;H,@P+<+_CBGM!"#ER1N.J/4+'$G[]*.06
ML6Z+=GRD< 0S(8A+Z_$R_$7C!2')RA9C)/R#(%57:)GJKV0W<FH\UQ)=C]4M
M"B'M#,AB=>FZ,WTH,?$GP 3L#R@Q"N]JY,7R^J_9<A"XX]D2B;=0(:0QE8V4
MW&P9%&31@"TJ:!;XP-IX3P75>2J ']:9.V/BRLB 5N12T,$U"#%G])1D*K#0
MB[!.E=&T9.45A%EMI/NX$XV1K0XPS;;D@OET?DH.,MLVD/0T5B21ZY4FB)ZC
MM$B!+0+A04]M)2M\W!I[SG>",+=Q)ALS)/=ITRU/P^[@ZH-2K1[L"BH1N%]:
M(<1B+I!BND$>%@UZD&$QET"5\55H]^VA*&RO8I>]9+ED^2.%OD:TCNR[(8IX
M 5<BS?#% HWS^H:4#))CYO,P0:K)T*!]UJ/C'V IC2GM2 E3$KK\@R*5S:*Z
M%NN-IDVW!QV@*8DL4:84J/ISQ.49"A8RP:U37],B/N EC->R-1)K,MMCM&KO
M@U! Y7U?+N_ \<.OL?-/>+$],A?;:Z0?D3^^G<L/?+V),<"WW$78!Y<%<UUC
M$BA/+5'LL8^ZR:E7>C\1+L/R<F0/*YIHBB[NCV2%Z_\P)Q.#LY;K13;)J5Z.
ME3Z10YEB-XTU*=;(JT$HPT)7OJP(< ?#R^O<NZQC#]D!/%CLA!S:[@W;O#;>
ME"'62==< $,+66'>MSJ?$_P-?QY:<ZK1YT4W[@ &%KF,L.=M ;PO!((?/S*#
MH-Q?Q\<@PE5B%W,C2*N,< &T>R[CGO,1(H*@LA9;$:A!>9R\8*N<=0#%6JTM
M;47^/G/Z#LS#:OLN Q(8\G#>C'WBUOAE6E2'RZ;[DW/*2;RH@35TS(.*&>L,
M,6TVG<(24-E:-\"6.OS.BMF.5O,JB2 _S=2.XMJ,1VY.R#;OBZ.SL,I431.)
M$X)8PRK63JQK ?=VDW:K?97/Q*F2[?B<G>+QK%M!;NK#F)$0<V5&XK,KD!QR
MB<ELB2Y:&ZHW"MOA8YS^7J  U@T'+XEKV5:!N"N,EIOS1C9BME0([#4(HHS)
M1\D[#J*^<(.H3]'X*DB+=^DZ^.;8([$91AP]"OB>^%_!= T-TGPB6S88=H6V
M37<*'6DSG=[E$I$VM8.-]WR7SH-,5F312K>$^ D=OKAI\'ZBKI\.N"K6[VR5
M<?I@,-+]TWZ)RX,8?6^D9I]4N,JKO"V]LCW<I*ZXEWPI% U/O@!#Y8C2B7#Y
MHN8P,@ 2B+W)MFQHJ,9]8KR.&5:LM"+>45?P@H;$%J]PN(H(0)RU;+'(C(.E
M(&DU+<EZ6%FVIEVZ[#"U-$;0:S3@[+O]?+19;AC'BQRXS'U&0*,[D%R2$@!%
M&9B:%>8;L8QZOCWKYCK!@O#?!N,@T.0"J\DD/HCD*H7#R&@2,^ +MAE88:0E
MP+#A?JZM6_WB?I]5F<-P6'2L%^;:-2NCB+.:[CG%!,;+<+>+:V8XF.?B'_/*
MU?YSC=4%UIR2=GTN=59"U(;9;K35PR(A8ZYZ;:<Y'(9I1KOS43IJ9M:A2'&V
M+I PDK;FD.NGN5>ITR>!0K?6J(A<O97R!0O!90YGIKH1DMI+)VO@9^"U(V9*
M\R%J7 W%E!EU>6!R9-Y6OQ#<;J>.DX#6ACCW4"H:^V9A=K\HG4XM$AM& (-R
MJ12AH>;V,CD,JL)-OQ;W41.L[Z,3,5Q[7\%72^($GH*)6A"#-[6N.!0$QY01
M4%H;J&[@>(3^""Y0NZFEI>ZZU37%=('XDEWE)H%\UQ)'(QR^/5-+2UP/LXZR
M)J9E#/H3U)$"4QF578(O. !T_#4 ] D#0$], .AM?9F5Q?]D^M']$A6?(<G9
M(*PJ,,8X,&]-+=O??%?^8,YPE!7X?\X7#(V.9 SPR6C73!K1:W4^WS2Y)A4%
M]S% /DSOZ/L$F8\X;E(^C!X;>.#VD6#_'J0W)U[YU+* R&^]!V!TRW]"-K0#
M4TPAEY\MN&TG:%MJ.JD*W].4<NJ[R]V1)11RS/Q^_]-[31/RJ[H &A"2OK]S
MTXJ(I)M,A>QV\%NMO*<=QYL?;=,3N$O)PG3I7O5Z5UYE6X@O<Z4)\9TUJ_#D
M;05"IKO.?2]J9YB<-X)_B((=*-[$E9%4H\V6@JG0UE2/L*HZ@+.F X8@'G7;
MPSY?P1G  !UM+O9 J-9UD;6V44");>8QL.D',>)%^@-JT $XWH*IB=LI4*6^
M$FJ[B$VRP#1F2F @<<8.B3.[IJEI9;D 7GSA$>H,XA%S9I9ZTPK#-*4**!7/
M$NP(,[598\[&7YO9I3*I,33:3CGEVOD=EMTF\9CTWME@;Q+6!AV/8D8H6(S@
MG1;-0D&RE]AGR&:MW?AH!W!I=]I9 D($BHLE$=F\CM7^<%I^GJM>KAI3!)LZ
M8R3V0NLM%]R;PHN 1**<QB7LQE?EW47=X< 51C$IAI@9K(IA07$UDHG)N2(K
MJ2F*8Q#5?%L74S,+F)F-99JE,+!%PK?Z.$,ES/.A6,'BF.\2*(=UY'BDKA6C
M[NDYC+DP:TF4"]XQ-34JZ[S4;4(V2;F&2-XJ)$S%\3$&2'(*&J20 DQ#L,@
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M9Z)M&1K!?;S+F5/C@Q%G? 8JUWDVI:R$(;H/B[1CI=D4L"8/8+ZIZ8]ET.O
MV)9S Y_LW]60-&A?P%$\BA+A^\!R'3:1N(M<1_@K=Q7DS ]8H#!PE%('OQNX
MGC\:![&S\.QN,>QIIZ>'H3K%89]:T?;*I9OD%,1XC> OEXQ6G=R^=:IJ \J
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M84GR'ZP-Y93\0%<E<Q_9FE- 4Y79J)?N,OTBFLVM%D?XEC<+$F2N2K>]7XA
MQR3"PO=$&LBR-MB465FLJ@T:%7H%:J!TFTSWT#5H@;2R=YL+8'!3ON#0W7=?
M0W<?+YL:14X,VE"=JAN# S+GRFBJF*VAC%2^%><8<6[A:.R>M?$>!5UP3QB:
MJ$GU.K1:&<=]=F&NT21JUZIBGXK B]H7293+ C4I08[\1H[V?(=/*CM('(LN
M#; WFF.41YMZMR.3_7;7/&(,!O@4OL0#7$H(G#+K%,UC!<:"=38GN0-4R5Q
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M8.@T=OXT&!-RM3KK)<N.> 86PEG( X^@:I"2-3+--D0 JR*.Z$-432[9H;Q
M&\[W/-/O;I0&89K(\R@JP#/?X=&M$"+3#_MJ6Y5'KJ#?V6="2R;Y$\7_1;5:
M;4J-PI\UV%2>J/(%#;_(*7WA-.:(W55I-"PN:1>D';@%A$3.O,MJ[-9+L;ZA
MHSOUQHZ5$S+V- BLNN=;KR=YFB>T9FIRS TM';'M@P[E"([7RN,2(5K4R0/A
MER;0@WDUU''3FT0;FDT9TJL95=-=L']T;"/8I)]VPQ!PC^E&D_V=EPSK65KR
M:/M$2]>_\PJZ-[$YNX)^0WO3[?CJCG^1S:3-(%TX)!R$PB-4\Y6AAG#@?SSZ
M" *N$.L@$W9T!BJ1;J3[3^)ZCBA9"[HC<38OWFV?2]93:J8B651B:*!(T3PB
M_5+Z)'^ FV(\LE8;MKD73M,\TF1#OB1&N[,SS2Y;LQ]39!XJ$P1$NGY8<K[(
M:HZ^)B=\28=5F)X!JHE*&W+C+<JL5<P+VA^3\] .M] H#KK:U, 4<VM89TD#
M$P$=AJ8GV$?V* 4=5(2FE,A]C<E2$/Q46B2BCF3)]KZ8R3'0[Z@QXAXE;8UT
ME)QKD!6/3Y<"5*M][.]X)BK/KH&$$&UZ7<6<@8Y]'2EUD^*,[Q]B.RRNSEAP
MTMUYC5[@W0,L*#<T$TL-[S>Y6%"RQ/QM5G3^%$D?7U53+<0);3WTN,/]Z8$H
M?(DQO^^^QOP^'K;J3VPN5M_*Q!FX7,:CN^DA;"VD(DSMSL";]:F=Y<+..ZVR
MR+/)Y%M!/,6+EFQ_D&:)A:@8GTO(8./F2'!!7!%+0XVM 4GWX&I=94MQ_LV)
MQGG-;(MG99AV6Z491"!E.*@"0*9DK'QCOYGF8W)O7BOZPSRX)0)(^W2E2-)"
M3:<S%*L_)Z<UR4'<2DW$+W*G6: @ZW%5,ZF<%CO?=#?2^@_GBUI0RY<VH@\0
MUC63B-Y53KZ<6SUC'L9"I^]#:[3E6A":K)D#7Y7<H(,]7_2EP0AU^M"%%T_J
MH:SAD]A_MM$$Z8IP?K0^]F-ECN*(O<,8_BQ)T_(F$%UWQ_B8;!=.89=I*B]8
M>=MCM%>BYW^=[2^%</+;Z9N7\'\7GV<6P3;>#F&8YWZ#%@O'V,+4L3C4@) O
M'^-14(2 'XEP#L&1%%V #'@K2M!K,7NU1KC.2IK="4C4LQIC",B+T+)S&B'Z
M?#EW>T.7@@%V.,+!T(%1X '4N@N"0/N]I25 MU,SZ?Y$@L3RMQ[8$)OA?W:6
M,PL\OTN[O(G;JL,;CWXW=!OD=B0'6>-2U&T;Q.%AZE7^(1=(=^-<+Q.CJO6*
M(5)]2XEE=!A8WEH;]/WW#QY]^_B_G)H@?!0\%B?+0B*Q+K4I$-WX !QY@BO(
M9>DTS=C&A]YMYWD)=TY-T7I9+E++8L8XD5$95%M=LF% , XQUTEN]JQP_[DG
M:OW7;T_>G"<7;\>CMZ]>G;TX?7=^UX%\3*UK.YB_KC"3=E$%M*);_/%(MK -
M&OY0!'2)>FQ5E?D-M2T#37"YR8B705IY3)8"FB1;Q:OORZA#2>)V_+!XG>%4
MA/B4F.4J9D6&VL%M$Q8\TCQ,0%*9N0P&,AW>LPE%2?Z!H4(UV+ZJOS,1DY3"
M!J3.LE :CGNS2(;882&<, I\:@HM&+D2O7$B#Y:LBO_XB>1',8DA44'3Q,0A
M3<8*X.FFEOR,_#P>:96=9+BW\8:#U, ]E3N[$0=<@B< 6DFZMV[M 4>I_077
MO?4$<6P$! [43<HOXRL6>]5*3<;:=..3=;MA=%LM/W?[6J%V1Z,8?I*[SKJ
MZ!.!O_(%QQ>^_QI?^$@7U#_WY0^<_NO%ZS_.S_YYFKQZ^^Z/WSY+I\!V8WU5
MU9O5_H%%?[ /&MX%$HML(A'2QK6;,/"[A THV4Z<XZ2T_DY*AEXL4"'7IF?#
M>2OVJ?8S1:3C3,MU\N42_\RP=(JY$+V73?;@")#31G _4@).+\;__Y-/[P(*
MJ[CBL3%9#,8?3'V8F,+"0M#A.?(<$9\@I?=A"A.94!6GD)-<%=72LJ=Q(@WT
M,>:*;K8P*SJXX=! J/W<?X01,4;?5H>_TOIQUQUXZK(:#<Y7B^HB[XE.#-N?
M!#/;R?C!6A*LE[_4[BB,U3+EEUNR7K<)J.#DKW:9>Y/G?\O!*!AFG:.+B^G1
MU)#_8";4:T.?4'U8X30QN4WN)O EJ=0R=:S-E&]^L AN^/C0I7T(<[HZ3(9W
M4O(PVIJ<J(&XR+GQ*L\L.<66$SX>Z1%_RAQ#5Q]%I+IG94>)XMRUC;K1)I;9
M\@&XOED!LYY54["@RMPWW\E)9XLK?I30=N0G)?(DCD]@K#>3\KMV2S%S$&E@
M3CDO;,0J4A)2BD4+-NI*@JO(RM!@Q0V70B+-)PP#847$$,&L6G"2FETY+PM>
M3C=V016EG*K#@8F]/*2K#0L;_CB5 (C'*8J6U&5%)014YNI1<9/:)J$*:Q2D
MJH#5;AYSZ%B"_RC)YR-Y;<"B%WN9!5O#Y^;7SI7EW4<P[:%)\IKT"/M^LMF3
M#W3WP\T=N?QO*]Q2?)G/,#R#K"B\W"1&)M[C;Q7\\@1./CS#MPQBZ]]R78K3
M2(<+I$ S9-2;NFE0 :-"[:HBN7.\%@Z/QZ.3:>NYW72R-UK/IOH4GXL'S*D[
M-R=-#I\ZF68XZ.$6C7.5%9)!GOF.L>._RDT3ZUJ9,@NYLF=2XTJ_?S#-#'=9
M = 20F"N3\$0U52#4IGS+6/MX,;J:IY3:@/VD>)O-]+QTOZ%LHF-7Q*6<8Z-
M@@K$9S81V)RV0*[U:=0=7H@RN!154DI\A4IC5*(3%KD!%;ZAT#O/=&FPECK'
M/9G?@FT]L< N.TLAXX'K[+J46BHG>$2,17K_FWB&)*5,>]-(?"<2,< 8_7AD
M,XT,BW70&U'<29!Z^B+]_Q^&_7_8G+<O_PV__/7BM]?/_S]02P$"% ,4
M" #R@9!:H@DM%#X#  !9"P  $0              @ $     86-A9"TR,#(U
M,#0Q-2YX<V102P$"% ,4    " #R@9!:T!0*/K4&  "G20  %0
M    @ %M P  86-A9"TR,#(U,#0Q-5]L86(N>&UL4$L! A0#%     @ \H&0
M6L_XKH/G!   ""X  !4              ( !50H  &%C860M,C R-3 T,35?
M<')E+GAM;%!+ 0(4 Q0    ( /*!D%HAS"E]=1D  !>Y   .
M  "  6\/  !D.3 U,C@R9#AK+FAT;5!+ 0(4 Q0    ( /*!D%I--16YR&L
M ",H @ 0              "  1 I  !D.3 U,C@R9&5X,S$N:'1M4$L%!@
0   %  4 /P$   :5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d905282d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="acad-20250415.xsd" xlink:type="simple"/>
    <context id="duration_2025-04-15_to_2025-04-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001070494</identifier>
        </entity>
        <period>
            <startDate>2025-04-15</startDate>
            <endDate>2025-04-15</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2025-04-15_to_2025-04-15"
      id="Hidden_dei_EntityRegistrantName">ACADIA PHARMACEUTICALS INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-511">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-04-15_to_2025-04-15"
      id="Hidden_dei_EntityCentralIndexKey">0001070494</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2025-04-15_to_2025-04-15"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2025-04-15_to_2025-04-15">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-523">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-524">2025-04-15</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-525">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-526">000-50768</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-527">06-1376651</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-528">12830 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-529">Suite 400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-530">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-531">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-532">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-533">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-534">558-2871</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-535">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-536">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-537">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-538">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-539">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-540">ACAD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-541">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-04-15_to_2025-04-15" id="ixv-542">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
